Patent Grant
9226767
The present application is related to the following, concurrently-filed U.S. patent applications, which are incorporated herein by reference in their entirety:
U.S. application Ser. No. 13/539,096, entitled “Haptic Feedback Devices for Surgical Robot,” now U.S. Patent Application Publication No. 2014-0005654 A1;
U.S. application Ser. No. 13/539,110, entitled “Lockout Mechanism for Use with Robotic Electrosurgical Device,” now U.S. Patent Application Publication No. 2014-0005654 A1;
U.S. application Ser. No. 13/538,588, entitled “Surgical Instruments with Articulating Shafts,” now U.S. Patent Application Publication No. 2014-0005701 A1;
U.S. application Ser. No. 13/538,601, entitled “Ultrasonic Surgical Instruments with Distally Positioned Transducers,” now U.S. Patent Application Publication No. 2014-0005702 A1;
U.S. application Ser. No. 13/538,700, entitled “Surgical Instruments with Articulating Shafts,” now U.S. Patent Application Publication No. 2014-0005703 A1;
U.S. application Ser. No. 13/538,711, entitled “Ultrasonic Surgical Instruments with Distally Positioned Jaw Assemblies,” now U.S. Patent Application Publication No. 2014-0005704 A1;
U.S. application Ser. No. 13/538,720, entitled “Surgical Instruments with Articulating Shafts,” now U.S. Patent Application Publication No. 2014-0005705 A1;
U.S. application Ser. No. 13/538,733, entitled “Ultrasonic Surgical Instruments with Control Mechanisms,”now U.S. Patent Application Publication No. 2014-0005681 A1; and
U.S. application Ser. No. 13/539,122, entitled “Surgical Instruments with Fluid Management System,” now U.S. Patent Application Publication No. 2014-0005668 A1.
The present disclosure relates generally to the field of robotic surgery. In particular, the present disclosure relates to, although not exclusively, electrosurgical instruments. More particularly, the present disclosure relates to, although not exclusively, a feedback control for an electrosurgical device.
Ultrasonic surgical devices, such as ultrasonic scalpels, are used in many applications in surgical procedures by virtue of their unique performance characteristics. Depending upon specific device configurations and operational parameters, ultrasonic surgical devices can provide substantially simultaneous transection of tissue and homeostasis by coagulation, desirably minimizing patient trauma. An ultrasonic surgical device comprises a proximally-positioned ultrasonic transducer and an instrument coupled to the ultrasonic transducer having a distally-mounted end effector comprising an ultrasonic blade to cut and seal tissue. The end effector is typically coupled either to a handle and/or a robotic surgical implement via a shaft. The blade is acoustically coupled to the transducer via a waveguide extending through the shaft. Ultrasonic surgical devices of this nature can be configured for open surgical use, laparoscopic, or endoscopic surgical procedures including robotic-assisted procedures.
Ultrasonic energy cuts and coagulates tissue using temperatures lower than those used in electrosurgical procedures. Vibrating at high frequencies (e.g., 55,500 times per second), the ultrasonic blade denatures protein in the tissue to form a sticky coagulum. Pressure exerted on tissue by the blade surface collapses blood vessels and allows the coagulum to form a haemostatic seal. A surgeon can control the cutting speed and coagulation by the force applied to the tissue by the end effector, the time over which the force is applied and the selected excursion level of the end effector.
Also used in many surgical applications are electrosurgical devices. Electrosurgical devices apply electrical energy to tissue in order to treat tissue. An electrosurgical device may comprise an instrument having a distally-mounted end effector comprising one or more electrodes. The end effector can be positioned against tissue such that electrical current is introduced into the tissue. Electrosurgical devices can be configured for bipolar or monopolar operation. During bipolar operation, current is introduced into and returned from the tissue by active and return electrodes, respectively, of the end effector. During monopolar operation, current is introduced into the tissue by an active electrode of the end effector and returned through a return electrode (e.g., a grounding pad) separately located on a patient's body. Heat generated by the current flow through the tissue may form hemostatic seals within the tissue and/or between tissues and thus may be particularly useful for sealing blood vessels, for example. The end effector of an electrosurgical device sometimes also comprises a cutting member that is movable relative to the tissue and the electrodes to transect the tissue.
Electrical energy applied by an electrosurgical device can be transmitted to the instrument by a generator. The electrical energy may be in the form of radio frequency (“RF”) energy. RF energy is a form of electrical energy that may be in the frequency range of 300 kHz to 1 MHz. During its operation, an electrosurgical device can transmit low frequency RF energy through tissue, which causes ionic agitation, or friction, in effect resistive heating, thereby increasing the temperature of the tissue. Because a sharp boundary may be created between the affected tissue and the surrounding tissue, surgeons can operate with a high level of precision and control, without sacrificing un-targeted adjacent tissue. The low operating temperatures of RF energy may be useful for removing, shrinking, or sculpting soft tissue while simultaneously sealing blood vessels. RF energy may work particularly well on connective tissue, which is primarily comprised of collagen and shrinks when contacted by heat.
Various example embodiments are directed towards a system and method for closed feedback control of a robotically controlled electrosurgical instrument. In one embodiment, the method comprises applying at least one electrosurgical signal to an electrosurgical end effector a robotically controlled surgical instrument. A feedback signal may be generated by the electrosurgical end effector and provided to a control logic. The control logic may be configured to determine a rate of change of the impedance of a target tissue based on the feedback signal received from the electrosurgical end effector. The control logic may be configured to control or modify the at least one electrosurgical signal such that the rate of change of impedance determined from the feedback signal is maintained at a predetermined rate or within a predetermined range.
The features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows:
Various example embodiments are directed towards a system and method for closed feedback control of a robotically controlled electrosurgical instrument. In one embodiment, the method comprises applying at least one electrosurgical signal to an electrosurgical end effector a robotically controlled surgical instrument. A feedback signal may be generated by the electrosurgical end effector and provided to a control logic. The control logic may be configured to determine a rate of change of the impedance of a target tissue based on the feedback signal received from the electrosurgical end effector. The control logic may be configured to control or modify the at least one electrosurgical signal such that the rate of change of impedance determined from the feedback signal is maintained at a predetermined rate or within a predetermined range.
Various example embodiments are directed towards modifying an electrosurgical drive signal. The drive signal may be configured to control a movement of an electrosurgical blade along a longitudinal axis of the electrosurgical end effector. The drive signal may be controlled by the control logic to adjust the speed of the electrosurgical blade. By altering the speed of the electrosurgical blade, the controller may maintain a rate of increase of impedance of a target tissue at a predetermined rate or within a predetermined range.
Other example embodiments are directed towards modifying an electrosurgical signal delivered to the electrosurgical end effector for treatment of the target tissue. Electrosurgical signals delivered to the electrosurgical end effector may include ultrasonic or radiofrequency (RF) signals. In one embodiment, an ultrasonic signal is applied to the electrosurgical blade to impart ultrasonic motion to the electrosurgical blade. In an another embodiment, a RF signal is applied to first and second electrodes located on the electrosurgical end effector to transfer the RF signal to the target tissue to cause welding of the target tissue. In yet another embodiment, both ultrasonic and RF energy may be applied to the electrosurgical end effector. The electrosurgical signal may be modified by the control logic to maintain a rate of increase of impedance of the target tissue at a predetermined rate or within a predetermined range.
Reference will now be made in detail to several embodiments, including embodiments showing example implementations of manual and robotic surgical instruments with end effectors comprising ultrasonic and/or electrosurgical elements. Wherever practicable similar or like reference numbers may be used in the figures and may indicate similar or like functionality. The figures depict example embodiments of the disclosed surgical instruments and/or methods of use for purposes of illustration only. One skilled in the art will readily recognize from the following description that alternative example embodiments of the structures and methods illustrated herein may be employed without departing from the principles described herein.
In various embodiments, the generator 20 comprises several functional elements, such as modules and/or blocks. Different functional elements or modules may be configured for driving different kinds of surgical devices. For example, an ultrasonic generator module 21 may drive an ultrasonic device, such as the ultrasonic surgical instrument 10. In some example embodiments, the generator 20 also comprises an electrosurgery/RF generator module 23 for driving an electrosurgical device (or an electrosurgical embodiment of the ultrasonic surgical instrument 10). In various embodiments, the generator 20 may be formed integrally within the handle assembly 12. In such implementations, a battery would be co-located within the handle assembly 12 to act as the energy source.
In some embodiments, the electrosurgery/RF generator module 23 may be configured to generate a therapeutic and/or sub-therapeutic energy level. In the example embodiment illustrated in
In one embodiment, the electrosurgical/RF generator module 23 may be implemented as an electrosurgery unit (ESU) capable of supplying power sufficient to perform bipolar electrosurgery using radio frequency (RF) energy. In one embodiment, the ESU can be a bipolar ERBE ICC 350 sold by ERBE USA, Inc. of Marietta, Ga. In bipolar electrosurgery applications, as previously discussed, a surgical instrument having an active electrode and a return electrode can be utilized, wherein the active electrode and the return electrode can be positioned against, or adjacent to, the tissue to be treated such that current can flow from the active electrode to the return electrode through the tissue. Accordingly, the electrosurgical/RF module 23 generator may be configured for therapeutic purposes by applying electrical energy to the tissue T sufficient for treating the tissue (e.g., cauterization).
In one embodiment, the electrosurgical/RF generator module 23 may be configured to deliver a sub-therapeutic RF signal to implement a tissue impedance measurement module. In one embodiment, the electrosurgical/RF generator module 23 comprises a bipolar radio frequency generator as described in more detail below. In one embodiment, the electrosurgical/RF generator module 12 may be configured to monitor electrical impedance Z, of tissue T and to control the characteristics of time and power level based on the tissue T by way of a return electrode on provided on a clamp member of the end effector assembly 26. Accordingly, the electrosurgical/RF generator module 23 may be configured for sub-therapeutic purposes for measuring the impedance or other electrical characteristics of the tissue T. Techniques and circuit configurations for measuring the impedance or other electrical characteristics of tissue T are discussed in more detail in commonly assigned U.S. Patent Publication No. 2011/0015631, titled “Electrosurgical Generator for Ultrasonic Surgical Instruments,” the disclosure of which is herein incorporated by reference in its entirety.
A suitable ultrasonic generator module 21 may be configured to functionally operate in a manner similar to the GEN300 sold by Ethicon Endo-Surgery, Inc. of Cincinnati, Ohio as is disclosed in one or more of the following U.S. patents, all of which are incorporated by reference herein: U.S. Pat. No. 6,480,796 (Method for Improving the Start Up of an Ultrasonic System Under Zero Load Conditions); U.S. Pat. No. 6,537,291 (Method for Detecting Blade Breakage Using Rate and/or Impedance Information); U.S. Pat. No. 6,662,127 (Method for Detecting Presence of a Blade in an Ultrasonic System); U.S. Pat. No. 6,679,899 (Method for Detecting Transverse Vibrations in an Ultrasonic Surgical System); U.S. Pat. No. 6,977,495 (Detection Circuitry for Surgical Handpiece System); U.S. Pat. No. 7,077,853 (Method for Calculating Transducer Capacitance to Determine Transducer Temperature); U.S. Pat. No. 7,179,271 (Method for Driving an Ultrasonic System to Improve Acquisition of Blade Resonance Frequency at Startup); and U.S. Pat. No. 7,273,483 (Apparatus and Method for Alerting Generator Function in an Ultrasonic Surgical System).
It will be appreciated that in various embodiments, the generator 20 may be configured to operate in several modes. In one mode, the generator 20 may be configured such that the ultrasonic generator module 21 and the electrosurgical/RF generator module 23 may be operated independently. One example of the independent operations of the ultrasonic generator module 21 and the electrosurgical/RF generator module 23 from the generator 20 is shown in
For example, the ultrasonic generator module 21 may be activated to apply ultrasonic energy to the end effector assembly 26 and subsequently, either therapeutic sub-therapeutic RF energy may be applied to the end effector assembly 26 by the electrosurgical/RF generator module 23. As previously discussed, the subtherapeutic electrosurgical/RF energy may be applied to tissue clamped between claim elements of the end effector assembly 26 to measure tissue impedance to control the activation, or modify the activation, of the ultrasonic generator module 21. Tissue impedance feedback from the application of the subtherapeutic energy also may be employed to activate a therapeutic level of the electrosurgical/RF generator module 23 to seal the tissue (e.g., vessel) clamped between claim elements of the end effector assembly 26.
In another embodiment, the ultrasonic generator module 21 and the electrosurgical/RF generator module 23 may be activated simultaneously. In one example, the ultrasonic generator module 21 is simultaneously activated with a sub-therapeutic RF energy level to measure tissue impedance simultaneously while the ultrasonic blade of the end effector assembly 26 cuts and coagulates the tissue (or vessel) clamped between the clamp elements of the end effector assembly 26. Such feedback may be employed, for example, to modify the drive output of the ultrasonic generator module 21. In another example, the ultrasonic generator module 21 may be driven simultaneously with electrosurgical/RF generator module 23 such that the ultrasonic blade portion of the end effector assembly 26 is employed for cutting the damaged tissue while the electrosurgical/RF energy is applied to electrode portions of the end effector clamp assembly 26 for sealing the tissue (or vessel).
When the generator 20 is activated via the triggering mechanism, in one embodiment electrical energy is continuously applied by the generator 20 to a transducer stack or assembly of the acoustic assembly. In another embodiment, electrical energy is intermittently applied (e.g., pulsed) by the generator 20. A phase-locked loop in the control system of the generator 20 may monitor feedback from the acoustic assembly. The phase lock loop adjusts the frequency of the electrical energy sent by the generator 20 to match the resonant frequency of the selected longitudinal mode of vibration of the acoustic assembly. In addition, a second feedback loop in the control system 25 maintains the electrical current supplied to the acoustic assembly at a pre-selected constant level in order to achieve substantially constant excursion at the end effector 18 of the acoustic assembly. In yet another embodiment, a third feedback loop in the control system 25 monitors impedance between electrodes located in the end effector assembly 26. Although
In ultrasonic operation mode, the electrical signal supplied to the acoustic assembly may cause the distal end of the end effector 18, to vibrate longitudinally in the range of, for example, approximately 20 kHz to 250 kHz. According to various embodiments, the blade 22 may vibrate in the range of about 54 kHz to 56 kHz, for example, at about 55.5 kHz. In other embodiments, the blade 22 may vibrate at other frequencies including, for example, about 31 kHz or about 80 kHz. The excursion of the vibrations at the blade can be controlled by, for example, controlling the amplitude of the electrical signal applied to the transducer assembly of the acoustic assembly by the generator 20. As noted above, the triggering mechanism of the generator 20 allows a user to activate the generator 20 so that electrical energy may be continuously or intermittently supplied to the acoustic assembly. The generator 20 also has a power line for insertion in an electro-surgical unit or conventional electrical outlet. It is contemplated that the generator 20 can also be powered by a direct current (DC) source, such as a battery. The generator 20 can comprise any suitable generator, such as Model No. GEN04, and/or Model No. GEN11 available from Ethicon Endo-Surgery, Inc.
In the illustrated embodiment, the trigger assembly 24 comprises a trigger 32 that operates in conjunction with a fixed handle 34. The fixed handle 34 and the trigger 32 are ergonomically formed and adapted to interface comfortably with the user. The fixed handle 34 is integrally associated with the handle assembly 12. The trigger 32 is pivotally movable relative to the fixed handle 34 as explained in more detail below with respect to the operation of the ultrasonic surgical instrument 10. The trigger 32 is pivotally movable in direction 33A toward the fixed handle 34 when the user applies a squeezing force against the trigger 32. A spring element 98 (
In one example embodiment, the trigger 32 comprises an elongated trigger hook 36, which defines an aperture 38 between the elongated trigger hook 36 and the trigger 32. The aperture 38 is suitably sized to receive one or multiple fingers of the user therethrough. The trigger 32 also may comprise a resilient portion 32a molded over the trigger 32 substrate. The overmolded resilient portion 32a is formed to provide a more comfortable contact surface for control of the trigger 32 in outward direction 33B. In one example embodiment, the overmolded resilient portion 32a may be provided over a portion of the elongated trigger hook 36. The proximal surface of the elongated trigger hook 32 remains uncoated or coated with a non-resilient substrate to enable the user to easily slide their fingers in and out of the aperture 38. In another embodiment, the geometry of the trigger forms a fully closed loop which defines an aperture suitably sized to receive one or multiple fingers of the user therethrough. The fully closed loop trigger also may comprise a resilient portion molded over the trigger substrate.
In one example embodiment, the fixed handle 34 comprises a proximal contact surface 40 and a grip anchor or saddle surface 42. The saddle surface 42 rests on the web where the thumb and the index finger are joined on the hand. The proximal contact surface 40 has a pistol grip contour that receives the palm of the hand in a normal pistol grip with no rings or apertures. The profile curve of the proximal contact surface 40 may be contoured to accommodate or receive the palm of the hand. A stabilization tail 44 is located towards a more proximal portion of the handle assembly 12. The stabilization tail 44 may be in contact with the uppermost web portion of the hand located between the thumb and the index finger to stabilize the handle assembly 12 and make the handle assembly 12 more controllable.
In one example embodiment, the switch assembly 28 may comprise a toggle switch 30. The toggle switch 30 may be implemented as a single component with a central pivot 304 located within inside the handle assembly 12 to eliminate the possibility of simultaneous activation. In one example embodiment, the toggle switch 30 comprises a first projecting knob 30a and a second projecting knob 30b to set the power setting of the ultrasonic transducer 16 between a minimum power level (e.g., MIN) and a maximum power level (e.g., MAX). In another embodiment, the rocker switch may pivot between a standard setting and a special setting. The special setting may allow one or more special programs to be implemented by the device. The toggle switch 30 rotates about the central pivot as the first projecting knob 30a and the second projecting knob 30b are actuated. The one or more projecting knobs 30a, 30b are coupled to one or more arms that move through a small arc and cause electrical contacts to close or open an electric circuit to electrically energize or de-energize the ultrasonic transducer 16 in accordance with the activation of the first or second projecting knobs 30a, 30b. The toggle switch 30 is coupled to the generator 20 to control the activation of the ultrasonic transducer 16. The toggle switch 30 comprises one or more electrical power setting switches to activate the ultrasonic transducer 16 to set one or more power settings for the ultrasonic transducer 16. The forces required to activate the toggle switch 30 are directed substantially toward the saddle point 42, thus avoiding any tendency of the instrument to rotate in the hand when the toggle switch 30 is activated.
In one example embodiment, the first and second projecting knobs 30a, 30b are located on the distal end of the handle assembly 12 such that they can be easily accessible by the user to activate the power with minimal, or substantially no, repositioning of the hand grip, making it suitable to maintain control and keep attention focused on the surgical site (e.g., a monitor in a laparoscopic procedure) while activating the toggle switch 30. The projecting knobs 30a, 30b may be configured to wrap around the side of the handle assembly 12 to some extent to be more easily accessible by variable finger lengths and to allow greater freedom of access to activation in awkward positions or for shorter fingers.
In the illustrated embodiment, the first projecting knob 30a comprises a plurality of tactile elements 30c, e.g., textured projections or “bumps” in the illustrated embodiment, to allow the user to differentiate the first projecting knob 30a from the second projecting knob 30b. It will be appreciated by those skilled in the art that several ergonomic features may be incorporated into the handle assembly 12. Such ergonomic features are described in U.S. Pat. No. 8,623,027 entitled “Ergonomic Surgical Instruments” which is incorporated by reference herein in its entirety.
In one example embodiment, the toggle switch 30 may be operated by the hand of the user. The user may easily access the first and second projecting knobs 30a, 30b at any point while also avoiding inadvertent or unintentional activation at any time. The toggle switch 30 may readily operated with a finger to control the power to the ultrasonic assembly 16 and/or to the ultrasonic assembly 16. For example, the index finger may be employed to activate the first contact portion 30a to turn on the ultrasonic assembly 16 to a maximum (MAX) power level. The index finger may be employed to activate the second contact portion 30b to turn on the ultrasonic assembly 16 to a minimum (MIN) power level. In another embodiment, the rocker switch may pivot the instrument 10 between a standard setting and a special setting. The special setting may allow one or more special programs to be implemented by the instrument 10. The toggle switch 30 may be operated without the user having to look at the first or second projecting knob 30a, 30b. For example, the first projecting knob 30a or the second projecting knob 30b may comprise a texture or projections to tactilely differentiate between the first and second projecting knobs 30a, 30b without looking.
In other embodiments, the trigger 32 and/or the toggle switch 30 may be employed to actuate the electrosurgical/RF generator module 23 individually or in combination with activation of the ultrasonic generator module 21.
In one example embodiment, the distal rotation assembly 13 is rotatable without limitation in either direction about a longitudinal axis “T.” The distal rotation assembly 13 is mechanically engaged to the elongated shaft assembly 14. The distal rotation assembly 13 is located on a distal end of the handle assembly 12. The distal rotation assembly 13 comprises a cylindrical hub 46 and a rotation knob 48 formed over the hub 46. The hub 46 mechanically engages the elongated shaft assembly 14. The rotation knob 48 may comprise fluted polymeric features and may be engaged by a finger (e.g., an index finger) to rotate the elongated shaft assembly 14. The hub 46 may comprise a material molded over the primary structure to form the rotation knob 48. The rotation knob 48 may be overmolded over the hub 46. The hub 46 comprises an end cap portion 46a that is exposed at the distal end. The end cap portion 46a of the hub 46 may contact the surface of a trocar during laparoscopic procedures. The hub 46 may be formed of a hard durable plastic such as polycarbonate to alleviate any friction that may occur between the end cap portion 46a and the trocar. The rotation knob 48 may comprise “scallops” or flutes formed of raised ribs 48a and concave portions 48b located between the ribs 48a to provide a more precise rotational grip. In one example embodiment, the rotation knob 48 may comprise a plurality of flutes (e.g., three or more flutes). In other embodiments, any suitable number of flutes may be employed. The rotation knob 48 may be formed of a softer polymeric material overmolded onto the hard plastic material. For example, the rotation knob 48 may be formed of pliable, resilient, flexible polymeric materials including Versaflex® TPE alloys made by GLS Corporation, for example. This softer overmolded material may provide a greater grip and more precise control of the movement of the rotation knob 48. It will be appreciated that any materials that provide adequate resistance to sterilization, are biocompatible, and provide adequate frictional resistance to surgical gloves may be employed to form the rotation knob 48.
In one example embodiment, the handle assembly 12 is formed from two (2) housing portions or shrouds comprising a first portion 12a and a second portion 12b. From the perspective of a user viewing the handle assembly 12 from the distal end towards the proximal end, the first portion 12a is considered the right portion and the second portion 12b is considered the left portion. Each of the first and second portions 12a, 12b includes a plurality of interfaces 69 (
In one example embodiment, the elongated endoscopic shaft assembly 14 comprises a proximal end 50 adapted to mechanically engage the handle assembly 12 and the distal rotation assembly 13; and a distal end 52 adapted to mechanically engage the end effector assembly 26. The elongated shaft assembly 14 comprises an outer tubular sheath 56 and a reciprocating tubular actuating member 58 located within the outer tubular sheath 56. The proximal end of the tubular reciprocating tubular actuating member 58 is mechanically engaged to the trigger 32 of the handle assembly 12 to move in either direction 60A or 60B in response to the actuation and/or release of the trigger 32. The pivotably moveable trigger 32 may generate reciprocating motion along the longitudinal axis “T.” Such motion may be used, for example, to actuate the jaws or clamping mechanism of the end effector assembly 26. A series of linkages translate the pivotal rotation of the trigger 32 to axial movement of a yoke coupled to an actuation mechanism, which controls the opening and closing of the jaws of the clamping mechanism of the end effector assembly 26. The distal end of the tubular reciprocating tubular actuating member 58 is mechanically engaged to the end effector assembly 26. In the illustrated embodiment, the distal end of the tubular reciprocating tubular actuating member 58 is mechanically engaged to a clamp arm assembly 64, which is pivotable about a pivot point 70, to open and close the clamp arm assembly 64 in response to the actuation and/or release of the trigger 32. For example, in the illustrated embodiment, the clamp arm assembly 64 is movable in direction 62A from an open position to a closed position about a pivot point 70 when the trigger 32 is squeezed in direction 33A. The clamp arm assembly 64 is movable in direction 62B from a closed position to an open position about the pivot point 70 when the trigger 32 is released or outwardly contacted in direction 33B.
In one example embodiment, the end effector assembly 26 is attached at the distal end 52 of the elongated shaft assembly 14 and includes a clamp arm assembly 64 and a blade 66. The jaws of the clamping mechanism of the end effector assembly 26 are formed by clamp arm assembly 64 and the blade 66. The blade 66 is ultrasonically actuatable and is acoustically coupled to the ultrasonic transducer 16. The trigger 32 on the handle assembly 12 is ultimately connected to a drive assembly, which together, mechanically cooperate to effect movement of the clamp arm assembly 64. Squeezing the trigger 32 in direction 33A moves the clamp arm assembly 64 in direction 62A from an open position, wherein the clamp arm assembly 64 and the blade 66 are disposed in a spaced relation relative to one another, to a clamped or closed position, wherein the clamp arm assembly 64 and the blade 66 cooperate to grasp tissue therebetween. The clamp arm assembly 64 may comprise a clamp pad (not shown) to engage tissue between the blade 66 and the clamp arm 64. Releasing the trigger 32 in direction 33B moves the clamp arm assembly 64 in direction 62B from a closed relationship, to an open position, wherein the clamp arm assembly 64 and the blade 66 are disposed in a spaced relation relative to one another.
The proximal portion of the handle assembly 12 comprises a proximal opening 68 to receive the distal end of the ultrasonic assembly 16. The ultrasonic assembly 16 is inserted in the proximal opening 68 and is mechanically engaged to the elongated shaft assembly 14.
In one example embodiment, the elongated trigger hook 36 portion of the trigger 32 provides a longer trigger lever with a shorter span and rotation travel. The longer lever of the elongated trigger hook 36 allows the user to employ multiple fingers within the aperture 38 to operate the elongated trigger hook 36 and cause the trigger 32 to pivot in direction 33B to open the jaws of the end effector assembly 26. For example, the user may insert three fingers (e.g., the middle, ring, and little fingers) in the aperture 38. Multiple fingers allows the surgeon to exert higher input forces on the trigger 32 and the elongated trigger hook 36 to activate the end effector assembly 26. The shorter span and rotation travel creates a more comfortable grip when closing or squeezing the trigger 32 in direction 33A or when opening the trigger 32 in the outward opening motion in direction 33B lessening the need to extend the fingers further outward. This substantially lessens hand fatigue and strain associated with the outward opening motion of the trigger 32 in direction 33B. The outward opening motion of the trigger may be spring-assisted by spring element 98 (
For example, during a surgical procedure either the index finger may be used to control the rotation of the elongated shaft assembly 14 to locate the jaws of the end effector assembly 26 in a suitable orientation. The middle and/or the other lower fingers may be used to squeeze the trigger 32 and grasp tissue within the jaws. Once the jaws are located in the desired position and the jaws are clamped against the tissue, the index finger can be used to activate the toggle switch 30 to adjust the power level of the ultrasonic transducer 16 to treat the tissue. Once the tissue has been treated, the user may release the trigger 32 by pushing outwardly in the distal direction against the elongated trigger hook 36 with the middle and/or lower fingers to open the jaws of the end effector assembly 26. This basic procedure may be performed without the user having to adjust their grip of the handle assembly 12.
As previously discussed, the clamp arm assembly 64 may comprise electrodes electrically coupled to the electrosurgical/RF generator module 23 to receive therapeutic and/or sub-therapeutic energy, where the electrosurgical/RF energy may be applied to the electrodes either simultaneously or non-simultaneously with the ultrasonic energy being applied to the blade 66. Such energy activations may be applied in any suitable combination to achieve a desired tissue effect in cooperation with an algorithm or other control logic.
In one example embodiment, an ultrasonic transmission waveguide 78 is disposed inside the reciprocating tubular actuating member 58. The distal end 52 of the ultrasonic transmission waveguide 78 is acoustically coupled (e.g., directly or indirectly mechanically coupled) to the blade 66 and the proximal end 50 of the ultrasonic transmission waveguide 78 is received within the handle assembly 12. The proximal end 50 of the ultrasonic transmission waveguide 78 is adapted to acoustically couple to the distal end of the ultrasonic transducer 16 as discussed in more detail below. The ultrasonic transmission waveguide 78 is isolated from the other elements of the elongated shaft assembly 14 by a protective sheath 80 and a plurality of isolation elements 82, such as silicone rings. The outer tubular sheath 56, the reciprocating tubular actuating member 58, and the ultrasonic transmission waveguide 78 are mechanically engaged by a pin 74. The switch assembly 28 comprises the toggle switch 30 and electrical elements 86a,b to electrically energize the ultrasonic transducer 16 in accordance with the activation of the first or second projecting knobs 30a, 30b.
In one example embodiment, the outer tubular sheath 56 isolates the user or the patient from the ultrasonic vibrations of the ultrasonic transmission waveguide 78. The outer tubular sheath 56 generally includes a hub 76. The outer tubular sheath 56 is threaded onto the distal end of the handle assembly 12. The ultrasonic transmission waveguide 78 extends through the opening of the outer tubular sheath 56 and the isolation elements 82 isolate the ultrasonic transmission waveguide 78 from the outer tubular sheath 56. The outer tubular sheath 56 may be attached to the waveguide 78 with the pin 74. The hole to receive the pin 74 in the waveguide 78 may occur nominally at a displacement node. The waveguide 78 may screw or snap into the hand piece handle assembly 12 by a stud. Flat portions on the hub 76 may allow the assembly to be torqued to a required level. In one example embodiment, the hub 76 portion of the outer tubular sheath 56 is preferably constructed from plastic and the tubular elongated portion of the outer tubular sheath 56 is fabricated from stainless steel. Alternatively, the ultrasonic transmission waveguide 78 may comprise polymeric material surrounding it to isolate it from outside contact.
In one example embodiment, the distal end of the ultrasonic transmission waveguide 78 may be coupled to the proximal end of the blade 66 by an internal threaded connection, preferably at or near an antinode. It is contemplated that the blade 66 may be attached to the ultrasonic transmission waveguide 78 by any suitable means, such as a welded joint or the like. Although the blade 66 may be detachable from the ultrasonic transmission waveguide 78, it is also contemplated that the single element end effector (e.g., the blade 66) and the ultrasonic transmission waveguide 78 may be formed as a single unitary piece.
In one example embodiment, the trigger 32 is coupled to a linkage mechanism to translate the rotational motion of the trigger 32 in directions 33A and 33B to the linear motion of the reciprocating tubular actuating member 58 in corresponding directions 60A and 60B. The trigger 32 comprises a first set of flanges 97 with openings formed therein to receive a first yoke pin 94a. The first yoke pin 94a is also located through a set of openings formed at the distal end of the yoke 84. The trigger 32 also comprises a second set of flanges 96 to receive a first end 92a of a link 92. A trigger pin 90 is received in openings formed in the link 92 and the second set of flanges 96. The trigger pin 90 is received in the openings formed in the link 92 and the second set of flanges 96 and is adapted to couple to the first and second portions 12a, 12b of the handle assembly 12 to form a trigger pivot point for the trigger 32. A second end 92b of the link 92 is received in a slot 93 formed in a proximal end of the yoke 84 and is retained therein by a second yoke pin 94b. As the trigger 32 is pivotally rotated about the pivot point 190 formed by the trigger pin 90, the yoke translates horizontally along longitudinal axis “T” in a direction indicated by arrows 60A,B.
In one example embodiment, the distal end of the end-bell 102 is connected to the proximal end of the transduction portion 100, and the proximal end of the fore-bell 104 is connected to the distal end of the transduction portion 100. The fore-bell 104 and the end-bell 102 have a length determined by a number of variables, including the thickness of the transduction portion 100, the density and modulus of elasticity of the material used to manufacture the end-bell 102 and the fore-bell 22, and the resonant frequency of the ultrasonic transducer 16. The fore-bell 104 may be tapered inwardly from its proximal end to its distal end to amplify the ultrasonic vibration amplitude as the velocity transformer 118, or alternately may have no amplification. A suitable vibrational frequency range may be about 20 Hz to 32 kHz and a well-suited vibrational frequency range may be about 30-10 kHz. A suitable operational vibrational frequency may be approximately 55.5 kHz, for example.
In one example embodiment, the piezoelectric elements 112 may be fabricated from any suitable material, such as, for example, lead zirconate-titanate, lead meta-niobate, lead titanate, barium titanate, or other piezoelectric ceramic material. Each of positive electrodes 114, negative electrodes 116, and the piezoelectric elements 112 has a bore extending through the center. The positive and negative electrodes 114 and 116 are electrically coupled to wires 120 and 122, respectively. The wires 120 and 122 are encased within the cable 22 and electrically connectable to the ultrasonic signal generator 20.
The ultrasonic transducer 16 of the acoustic assembly 106 converts the electrical signal from the ultrasonic signal generator 20 into mechanical energy that results in primarily a standing acoustic wave of longitudinal vibratory motion of the ultrasonic transducer 16 and the blade 66 portion of the end effector assembly 26 at ultrasonic frequencies. In another embodiment, the vibratory motion of the ultrasonic transducer may act in a different direction. For example, the vibratory motion may comprise a local longitudinal component of a more complicated motion of the tip of the elongated shaft assembly 14. A suitable generator is available as model number GEN11, from Ethicon Endo-Surgery, Inc., Cincinnati, Ohio. When the acoustic assembly 106 is energized, a vibratory motion standing wave is generated through the acoustic assembly 106. The ultrasonic surgical instrument 10 is designed to operate at a resonance such that an acoustic standing wave pattern of predetermined amplitude is produced. The amplitude of the vibratory motion at any point along the acoustic assembly 106 depends upon the location along the acoustic assembly 106 at which the vibratory motion is measured. A minimum or zero crossing in the vibratory motion standing wave is generally referred to as a node (i.e., where motion is minimal), and a local absolute value maximum or peak in the standing wave is generally referred to as an anti-node (i.e., where local motion is maximal). The distance between an anti-node and its nearest node is one-quarter wavelength (λ/4).
The wires 120 and 122 transmit an electrical signal from the ultrasonic signal generator 20 to the positive electrodes 114 and the negative electrodes 116. The piezoelectric elements 112 are energized by the electrical signal supplied from the ultrasonic signal generator 20 in response to an actuator 224, such as a foot switch, for example, to produce an acoustic standing wave in the acoustic assembly 106. The electrical signal causes disturbances in the piezoelectric elements 112 in the form of repeated small displacements resulting in large alternating compression and tension forces within the material. The repeated small displacements cause the piezoelectric elements 112 to expand and contract in a continuous manner along the axis of the voltage gradient, producing longitudinal waves of ultrasonic energy. The ultrasonic energy is transmitted through the acoustic assembly 106 to the blade 66 portion of the end effector assembly 26 via a transmission component or an ultrasonic transmission waveguide portion 78 of the elongated shaft assembly 14.
In one example embodiment, in order for the acoustic assembly 106 to deliver energy to the blade 66 portion of the end effector assembly 26, all components of the acoustic assembly 106 must be acoustically coupled to the blade 66. The distal end of the ultrasonic transducer 16 may be acoustically coupled at the surface 110 to the proximal end of the ultrasonic transmission waveguide 78 by a threaded connection such as a stud 124.
In one example embodiment, the components of the acoustic assembly 106 are preferably acoustically tuned such that the length of any assembly is an integral number of one-half wavelengths (nλ/2), where the wavelength λ is the wavelength of a pre-selected or operating longitudinal vibration drive frequency fd of the acoustic assembly 106. It is also contemplated that the acoustic assembly 106 may incorporate any suitable arrangement of acoustic elements.
In one example embodiment, the blade 66 may have a length substantially equal to an integral multiple of one-half system wavelengths (nλ/2). A distal end of the blade 66 may be disposed near an antinode in order to provide the maximum longitudinal excursion of the distal end. When the transducer assembly is energized, the distal end of the blade 66 may be configured to move in the range of, for example, approximately 10 to 500 microns peak-to-peak, and preferably in the range of about 30 to 64 microns at a predetermined vibrational frequency of 55 kHz, for example.
In one example embodiment, the blade 66 may be coupled to the ultrasonic transmission waveguide 78. The blade 66 and the ultrasonic transmission waveguide 78 as illustrated are formed as a single unit construction from a material suitable for transmission of ultrasonic energy. Examples of such materials include Ti6Al4V (an alloy of Titanium including Aluminum and Vanadium), Aluminum, Stainless Steel, or other suitable materials. Alternately, the blade 66 may be separable (and of differing composition) from the ultrasonic transmission waveguide 78, and coupled by, for example, a stud, weld, glue, quick connect, or other suitable known methods. The length of the ultrasonic transmission waveguide 78 may be substantially equal to an integral number of one-half wavelengths (nλ/2), for example. The ultrasonic transmission waveguide 78 may be preferably fabricated from a solid core shaft constructed out of material suitable to propagate ultrasonic energy efficiently, such as the titanium alloy discussed above (i.e., Ti6Al4V) or any suitable aluminum alloy, or other alloys, for example.
In one example embodiment, the ultrasonic transmission waveguide 78 comprises a longitudinally projecting attachment post at a proximal end to couple to the surface 110 of the ultrasonic transmission waveguide 78 by a threaded connection such as the stud 124. The ultrasonic transmission waveguide 78 may include a plurality of stabilizing silicone rings or compliant supports 82 (
The distal end of the cylindrical hub 135 comprises a circumferential lip 132 and a circumferential bearing surface 140. The circumferential lip engages a groove formed in the housing 12 and the circumferential bearing surface 140 engages the housing 12. Thus, the cylindrical hub 135 is mechanically retained within the two housing portions (not shown) of the housing 12. The circumferential lip 132 of the cylindrical hub 135 is located or “trapped” between the first and second housing portions 12a, 12b and is free to rotate in place within the groove. The circumferential bearing surface 140 bears against interior portions of the housing to assist proper rotation. Thus, the cylindrical hub 135 is free to rotate in place within the housing. The user engages the flutes 136 formed on the proximal rotation knob 134 with either the finger or the thumb to rotate the cylindrical hub 135 within the housing 12.
In one example embodiment, the cylindrical hub 135 may be formed of a durable plastic such as polycarbonate. In one example embodiment, the cylindrical hub 135 may be formed of a siliconized polycarbonate material. In one example embodiment, the proximal rotation knob 134 may be formed of pliable, resilient, flexible polymeric materials including Versaflex® TPE alloys made by GLS Corporation, for example. The proximal rotation knob 134 may be formed of elastomeric materials, thermoplastic rubber known as Santoprene®, other thermoplastic vulcanizates (TPVs), or elastomers, for example. The embodiments, however, are not limited in this context.
The electrosurgical system 300 can be configured to supply energy, such as electrical energy, ultrasonic energy, heat energy, or any combination thereof, to the tissue of a patient either independently or simultaneously as described, for example, in connection with
The generator 320 may comprise an input device 335 located on a front panel of the generator 320 console. The input device 335 may comprise any suitable device that generates signals suitable for programming the operation of the generator 320, such as a keyboard, or input port, for example. In one example embodiment, various electrodes in the first jaw 364A and the second jaw 364B may be coupled to the generator 320. The cable 322 may comprise multiple electrical conductors for the application of electrical energy to positive (+) and negative (−) electrodes of the electrosurgical instrument 310. The control unit 325 may be used to activate the generator 320, which may serve as an electrical source. In various embodiments, the generator 320 may comprise an RF source, an ultrasonic source, a direct current source, and/or any other suitable type of electrical energy source, for example, which may be activated independently or simultaneously.
In various embodiments, the electrosurgical system 300 may comprise at least one supply conductor 331 and at least one return conductor 333, wherein current can be supplied to electrosurgical instrument 300 via the supply conductor 331 and wherein the current can flow back to the generator 320 via the return conductor 333. In various embodiments, the supply conductor 331 and the return conductor 333 may comprise insulated wires and/or any other suitable type of conductor. In certain embodiments, as described below, the supply conductor 331 and the return conductor 333 may be contained within and/or may comprise the cable 322 extending between, or at least partially between, the generator 320 and the end effector 326 of the electrosurgical instrument 310. In any event, the generator 320 can be configured to apply a sufficient voltage differential between the supply conductor 331 and the return conductor 333 such that sufficient current can be supplied to the end effector 110.
The end effector 326 may be adapted for capturing and transecting tissue and for the contemporaneously welding the captured tissue with controlled application of energy (e.g., RF energy). The first jaw 364A and the second jaw 364B may close to thereby capture or engage tissue about a longitudinal axis “T” defined by the axially moveable member 378. The first jaw 364A and second jaw 364B may also apply compression to the tissue. In some embodiments, the elongated shaft 314, along with first jaw 364A and second jaw 364B, can be rotated a full 360° degrees, as shown by arrow 196 (see
The lever arm 321 of the handle 312 (
More specifically, referring now to
The first energy delivery surface 365A and the second energy delivery surface 365B may each be in electrical communication with the generator 320. The first energy delivery surface 365A and the second energy delivery surface 365B may be configured to contact tissue and deliver electrosurgical energy to captured tissue which are adapted to seal or weld the tissue. The control unit 325 regulates the electrical energy delivered by electrical generator 320 which in turn delivers electrosurgical energy to the first energy delivery surface 365A and the second energy delivery surface 365B. The energy delivery may be initiated by an activation button 328 (
As mentioned above, the electrosurgical energy delivered by electrical generator 320 and regulated, or otherwise controlled, by the control unit 325 may comprise radio frequency (RF) energy, or other suitable forms of electrical energy. Further, the opposing first and second energy delivery surfaces 365A and 365B may carry variable resistive positive temperature coefficient (PTC) bodies that are in electrical communication with the generator 320 and the control unit 325. Additional details regarding electrosurgical end effectors, jaw closing mechanisms, and electrosurgical energy-delivery surfaces are described in the following U.S. patents and published patent applications: U.S. Pat. Nos. 7,087,054; 7,083,619; 7,070,597; 7,041,102; 7,011,657; 6,929,644; 6,926,716; 6,913,579; 6,905,497; 6,802,843; 6,770,072; 6,656,177; 6,533,784; and 6,500,312; and U.S. Pat. App. Pub. Nos. 2010/0036370 and 2009/0076506, all of which are incorporated herein in their entirety by reference and made a part of this specification.
In one example embodiment, the generator 320 may be implemented as an electrosurgery unit (ESU) capable of supplying power sufficient to perform bipolar electrosurgery using radio frequency (RF) energy. In one example embodiment, the ESU can be a bipolar ERBE ICC 350 sold by ERBE USA, Inc. of Marietta, Ga. In some embodiments, such as for bipolar electrosurgery applications, a surgical instrument having an active electrode and a return electrode can be utilized, wherein the active electrode and the return electrode can be positioned against, adjacent to and/or in electrical communication with, the tissue to be treated such that current can flow from the active electrode, through the positive temperature coefficient (PTC) bodies and to the return electrode through the tissue. Thus, in various embodiments, the electrosurgical system 300 may comprise a supply path and a return path, wherein the captured tissue being treated completes, or closes, the circuit. In one example embodiment, the generator 320 may be a monopolar RF ESU and the electrosurgical instrument 310 may comprise a monopolar end effector 326 in which one or more active electrodes are integrated. For such a system, the generator 320 may require a return pad in intimate contact with the patient at a location remote from the operative site and/or other suitable return path. The return pad may be connected via a cable to the generator 320. In other embodiments, the operator 20 may provide sub-therapeutic RF energy levels for purposes of evaluating tissue conditions and providing feedback in the electrosurgical system 300. Such feed back may be employed to control the therapeutic RF energy output of the electrosurgical instrument 310.
During operation of electrosurgical instrument 300, the user generally grasps tissue, supplies energy to the captured tissue to form a weld or a seal (e.g., by actuating button 328 and/or pedal 216), and then drives a tissue-cutting element 371 at the distal end of the axially moveable member 378 through the captured tissue. According to various embodiments, the translation of the axial movement of the axially moveable member 378 may be paced, or otherwise controlled, to aid in driving the axially moveable member 378 at a suitable rate of travel. By controlling the rate of the travel, the likelihood that the captured tissue has been properly and functionally sealed prior to transection with the cutting element 371 is increased.
In one example embodiment, various electrodes in the end effector 326 (including jaws 364A, 364B thereof) may be coupled to the generator circuit 420. The control circuit may be used to activate the generator 420, which may serve as an electrical source. In various embodiments, the generator 420 may comprise an RF source, an ultrasonic source, a direct current source, and/or any other suitable type of electrical energy source, for example. In one example embodiment, a button 328 may be provided to activate the generator circuit 420 to provide energy to the end effectors 326, 326.
In one example embodiment, the cordless electrosurgical instrument comprises a battery 437. The battery 437 provides electrical energy to the generator circuit 420. The battery 437 may be any battery suitable for driving the generator circuit 420 at the desired energy levels. In one example embodiment, the battery 437 is a 100mAh, triple-cell Lithium Ion Polymer battery. The battery may be fully charged prior to use in a surgical procedure, and may hold a voltage of about 12.6V. The battery 437 may have two fuses fitted to the cordless electrosurgical instrument 410, arranged in line with each battery terminal. In one example embodiment, a charging port 439 is provided to connect the battery 437 to a DC current source (not shown).
The generator circuit 420 may be configured in any suitable manner. In some embodiments, the generator circuit comprises an RF drive and control circuit 440.
As shown in
As shown in
In one embodiment, the transformer 455 may be implemented with a Core Diameter (mm), Wire Diameter (mm), and Gap between secondary windings in accordance with the following specifications:
Core Diameter, D (mm)
D=19.9×10−3
Wire diameter, W (mm) for 22 AWG wire
W=7.366×10−4
Gap between secondary windings, in gap=0.125
G=gap/25.4
In this embodiment, the amount of electrical power supplied to the end effector 326 is controlled by varying the frequency of the switching signals used to switch the FETs 443. This works because the resonant circuit 450 acts as a frequency dependent (loss less) attenuator. The closer the drive signal is to the resonant frequency of the resonant circuit 450, the less the drive signal is attenuated. Similarly, as the frequency of the drive signal is moved away from the resonant frequency of the circuit 450, the more the drive signal is attenuated and so the power supplied to the load reduces. In this embodiment, the frequency of the switching signals generated by the FET gate drive circuitry 445 is controlled by a controller 481 based on a desired power to be delivered to the load 459 and measurements of the load voltage (VL) and of the load current (IL) obtained by conventional voltage sensing circuitry 483 and current sensing circuitry 485. The way that the controller 481 operates will be described in more detail below.
In one embodiment, the voltage sensing circuitry 483 and the current sensing circuitry 485 may be implemented with high bandwidth, high speed rail-to-rail amplifiers (e.g., LMH6643 by National Semiconductor). Such amplifiers, however, consume a relatively high current when they are operational. Accordingly, a power save circuit may be provided to reduce the supply voltage of the amplifiers when they are not being used in the voltage sensing circuitry 483 and the current sensing circuitry 485. In one-embodiment, a step-down regulator (e.g., LT3502 by Linear Technologies) may be employed by the power save circuit to reduce the supply voltage of the rail-to-rail amplifiers and thus extend the life of the battery 437.
The frequency control module 495 uses the values obtained from the calculation module 493 and the power set point (Pset) obtained from the medical device control module 497 and predefined system limits (to be explained below), to determine whether or not to increase or decrease the applied frequency. The result of this decision is then passed to a square wave generation module 463 which, in this embodiment, increments or decrements the frequency of a square wave signal that it generates by 1 kHz, depending on the received decision. As those skilled in the art will appreciate, in an alternative embodiment, the frequency control module 495 may determine not only whether to increase or decrease the frequency, but also the amount of frequency change required. In this case, the square wave generation module 463 would generate the corresponding square wave signal with the desired frequency shift. In this embodiment, the square wave signal generated by the square wave generation module 463 is output to the FET gate drive circuitry 445, which amplifies the signal and then applies it to the FET 443-1. The FET gate drive circuitry 445 also inverts the signal applied to the FET 443-1 and applies the inverted signal to the FET 443-2.
The electrosurgical instrument 410 may comprise additional features as discussed with respect to electrosurgical system 300. Those skilled in the art will recognize that electrosurgical instrument 410 may include a rotation knob 348, an elongate shaft 314, and an end effector 326. These elements function in a substantially similar manner to that discussed above with respect to the electrosurgical system 300. In one example embodiment, the cordless electrosurgical instrument 410 may include visual indicators 435. The visual indicators 435 may provide a visual indication signal to an operator. In one example embodiment, the visual indication signal may alert an operator that the device is on, or that the device is applying energy to the end effector. Those skilled in the art will recognize that the visual indicators 435 may be configured to provide information on multiple states of the device.
Over the years a variety of minimally invasive robotic (or “telesurgical”) systems have been developed to increase surgical dexterity as well as to permit a surgeon to operate on a patient in an intuitive manner. Robotic surgical systems can be used with many different types of surgical instruments including, for example, ultrasonic or electrosurgical instruments, as described herein. Example robotic systems include those manufactured by Intuitive Surgical, Inc., of Sunnyvale, Calif., U.S.A. Such systems, as well as robotic systems from other manufacturers, are disclosed in the following U.S. Patents which are each herein incorporated by reference in their respective entirety: U.S. Pat. No. 5,792,135, entitled “Articulated Surgical Instrument For Performing Minimally Invasive Surgery With Enhanced Dexterity and Sensitivity”, U.S. Pat. No. 6,231,565, entitled “Robotic Arm DLUS For Performing Surgical Tasks”, U.S. Pat. No. 6,783,524, entitled “Robotic Surgical Tool With Ultrasound Cauterizing and Cutting Instrument”, U.S. Pat. No. 6,364,888, entitled “Alignment of Master and Slave In a Minimally Invasive Surgical Apparatus”, U.S. Pat. No. 7,524,320, entitled “Mechanical Actuator Interface System For Robotic Surgical Tools”, U.S. Pat. No. 7,691,098, entitled Platform Link Wrist Mechanism”, U.S. Pat. No. 7,806,891, entitled “Repositioning and Reorientation of Master/Slave Relationship in Minimally Invasive Telesurgery”, and U.S. Pat. No. 7,824,401, entitled “Surgical Tool With Writed Monopolar Electrosurgical End Effectors”. Many of such systems, however, have in the past been unable to generate the magnitude of forces required to effectively cut and fasten tissue.
Interface 560 also includes an adaptor portion 568 that is configured to mountingly engage the mounting plate 562 as will be further discussed below. The adaptor portion 568 may include an array of electrical connecting pins 570, which may be coupled to a memory structure by a circuit board within the instrument mounting portion 558. While interface 560 is described herein with reference to mechanical, electrical, and magnetic coupling elements, it should be understood that a wide variety of telemetry modalities might be used, including infrared, inductive coupling, or the like.
Openings 590 on the instrument side 572 and openings 590 on the holder side 574 of rotatable bodies 576 are configured to accurately align the driven elements 564 (
Various embodiments may further include an array of electrical connector pins 570 located on holder side 574 of adaptor 568, and the instrument side 572 of the adaptor 568 may include slots 594 (
A detachable latch arrangement 598 may be employed to releasably affix the adaptor 568 to the instrument holder 588. As used herein, the term “instrument drive assembly” when used in the context of the robotic system, at least encompasses various embodiments of the adapter 568 and instrument holder 588 and which has been generally designated as 546 in
As described the driven elements 564 may be aligned with the drive elements 592 of the instrument holder 588 such that rotational motion of the drive elements 592 causes corresponding rotational motion of the driven elements 564. The rotation of the drive elements 592 and driven elements 564 may be electronically controlled, for example, via the robotic arm 512, in response to instructions received from the clinician 502 via a controller 508. The instrument mounting portion 558 may translate rotation of the driven elements 564 into motion of the surgical instrument 522, 523.
In one example embodiment, the instrument mounting portion 558 comprises a mechanism for translating rotation of the various driven elements 564 into rotation of the shaft 538, differential translation of members along the axis of the shaft (e.g., for articulation), and reciprocating translation of one or more members along the axis of the shaft 538 (e.g., for extending and retracting tissue cutting elements such as 555, overtubes and/or other components). In one example embodiment, the rotatable bodies 612 (e.g., rotatable spools) are coupled to the driven elements 564. The rotatable bodies 612 may be formed integrally with the driven elements 564. In some embodiments, the rotatable bodies 612 may be formed separately from the driven elements 564 provided that the rotatable bodies 612 and the driven elements 564 are fixedly coupled such that driving the driven elements 564 causes rotation of the rotatable bodies 612. Each of the rotatable bodies 612 is coupled to a gear train or gear mechanism to provide shaft articulation and rotation and clamp jaw open/close and knife actuation.
In one example embodiment, the instrument mounting portion 558 comprises a mechanism for causing differential translation of two or more members along the axis of the shaft 538. In the example provided in
In one example embodiment, the instrument mounting portion 558 further comprises a mechanism for translating rotation of the driven elements 564 into rotational motion about the axis of the shaft 538. For example, the rotational motion may be rotation of the shaft 538 itself. In the illustrated embodiment, a first spiral worm gear 630 coupled to a rotatable body 612 and a second spiral worm gear 632 coupled to the shaft assembly 538. A bearing 616 (
In one example embodiment, the instrument mounting portion 558 comprises a mechanism for generating reciprocating translation of one or more members along the axis of the shaft 538. Such translation may be used, for example to drive a tissue cutting element, such as 555, drive an overtube for closure and/or articulation of the end effector 610, etc. In the illustrated embodiment, for example, a rack and pinion gearing mechanism may provide the reciprocating translation. A first gear 636 is coupled to a rotatable body 612 such that rotation of the corresponding driven element 564 causes the first gear 636 to rotate in a first direction. A second gear 638 is free to rotate about a post 640 formed in the instrument mounting plate 562. The first gear 636 is meshed to the second gear 638 such that the second gear 638 rotates in a direction that is opposite of the first gear 636. In one example embodiment, the second gear 638 is a pinion gear meshed to a rack gear 642, which moves in a liner direction. The rack gear 642 is coupled to a translating block 644, which may translate distally and proximally with the rack gear 642. The translation block 644 may be coupled to any suitable component of the shaft assembly 538 and/or the end effector 610 so as to provide reciprocating longitudinal motion. For example, the translation block 644 may be mechanically coupled to the tissue cutting element 555 of the RF surgical device 523. In some embodiments, the translation block 644 may be coupled to an overtube, or other component of the end effector 610 or shaft 538.
Referring now to the alternate example mechanism for generating reciprocating translation of one or more members along the axis of the shaft 538, the instrument mounting portion 558 comprises a rack and pinion gearing mechanism to provide reciprocating translation along the axis of the shaft 538 (e.g., translation of a tissue cutting element 555 of the RF surgical device 523). In one example embodiment, a third pinion gear 660 is coupled to a rotatable body 612 such that rotation of the corresponding driven element 564 causes the third pinion gear 660 to rotate in a first direction. The third pinion gear 660 is meshed to a rack gear 662, which moves in a linear direction. The rack gear 662 is coupled to a translating block 664. The translating block 664 may be coupled to a component of the device 522, 523, such as, for example, the tissue cutting element 555 of the RF surgical device and/or an overtube or other component which is desired to be translated longitudinally.
In various embodiments, the instrument mounting portion 558 may additionally comprise internal energy sources for driving electronics and provided desired ultrasonic and/or RF frequency signals to surgical tools.
As illustrated in
In one embodiment, an electrosurgical end effector may be controlled to ensure proper sealing of a target tissue during operation.
The electrosurgical instrument 700 may be integrated with the robotic surgical system shown in
In one embodiment, a control logic 726 is coupled to the motor control logic 712 and the electrosurgical end effector 722. In one embodiment, the control logic 726 may be configured to modify the one or more signals applied to the electrosurgical end effector 722. For example, the control logic 726 may provide a control signal to the motor control logic 712 to adjust the speed of the motor 714. As another example, the control logic 726 may be coupled to a generator to control an ultrasonic or radiofrequency signal generated by the generator and applied to the electrosurgical end effector 722. The control logic 726 may be implemented in any suitable digital logic circuit, such as, for example, a processor, a digital signal processor, a state-machine implemented by a field programmable gate array (FPGA), or any other suitable logic circuit. The control logic 726 may be implemented in hardware, software, or any combination thereof.
In one embodiment, the first and second electrodes 709a, 709b receive an electrosurgical signal 728, such as, for example, an RF signal. The RF signal may be a therapeutic or sub-therapeutic RF signal. The electrosurgical signal 728 may be generated by a generator, such as, for example, the generator 320 shown in, and described in connection with,
In one embodiment, a first feedback signal 710 is generated by the conducting energy trough the target tissue 707 and is transmitted to the control logic 726. In one embodiment, the energy conducted by the target tissue 707 for purposes of operating the first feedback signal 710 may be therapeutic, sub-therapeutic, or a combination thereof. The feedback signal 710 may, in one embodiment, be a measurement of the impedance of the target tissue 707. As the target tissue 707 is cut and sealed, the impedance of the target tissue 707 increases proportionally. By measuring the increase in impedance, the control logic 726 may determine whether the electrosurgical end effector 722 is properly sealing and cutting the target tissue 707 and apply any suitable control signal in response thereto. The control logic 726 may adjust the reciprocating movement speed of the blade 724, the energy level of the electrosurgical signal 728, or any combination thereof, in order to ensure that the target tissue 707 is suitably sealed.
In one embodiment, the motor 714 may comprise a servo motor. A servo motor is a motor which forms part of a servomechanism. In one embodiment, an encoder is located on the shaft of the servo motor to provide a feedback signal to the motor control logic 712. The encoder may be any suitable encoder for use with a servo motor, such as, for example, a rotary encoder which may provide a signal indicative of a rotational position. In one embodiment, the rotation of a shaft of the servo motor may correspond to a movement of the blade 724. For example, a rotary encoder may be disposed on the shaft of the servo motor. Each rotational degree of the servo motor may correspond to a specific distal movement distance of the blade 724. The motor control logic 712 may receive a signal from the encoder and may convert the signal into a position of the blade 724 based on the known ratio between the rotation of the shaft and the distal movement of the blade 724.
In another embodiment, the motor 714 may comprise a stepper motor. A stepper motor is a brushless DC motor that divides a full rotation of the motor into a number of equal steps. The motor's position can be controlled by a pulsed DC signal causing the motor to advance a certain number of steps with each pulse. In one embodiment, a single step of a stepper motor may correspond to a known distal movement distance of the blade 724. The position of the blade 724 can be precisely controlled by applying a pulsed control signal to the stepper motor. In one embodiment, the motor control logic 712 may generate the pulsed DC control signal for the stepper motor based on input from the control logic 726, one or more feedback signals 710, 710′ received from the end effector, or any combination thereof.
In one embodiment, the control logic 726 may maintain a rate of increase of the impedance by varying the speed of the motor 714. The control logic 726 may provide a control signal to the motor control logic 712. The motor control logic 712 may vary the output signal to the motor 714 to increase or decrease the longitudinal speed of the blade 724 to ensure proper cutting and sealing of the target tissue 707. The motor control logic 712 may be any suitable motor controller, such as, for example, an adjustable-speed driver or an intelligent motor controller. An adjustable-speed driver is a control circuit that may vary the output voltage or current to the motor resulting in the motor running at faster or slower speeds, proportional to the voltage. An intelligent motor controller is a logic circuit which may control the voltage, current, or other output to the motor to increase or decrease the longitudinal speed. The motor control logic 712 may be implemented in any suitable digital logic circuit, such as, for example, a processor, a digital signal processor, a state machine implemented by a field programmable gate array (FPGA), or any other suitable logic circuit. The motor control logic 712 may be implemented in hardware, software, or any combination thereof.
The control logic 726 and the motor control logic 712 may comprise one or more circuit components for converting or generating control signals. In one embodiment, the motor control logic 712 may comprise a Digital-to-Analog Converter (DAC) to convert a digital control signal from the control logic 726 to an analog input signal for the motor 714. In other embodiments, the control logic 726 or the motor control logic 712 may comprise one or more components for generating a pulse-width modulation signal for controlling the motor 714, including, but not limited to, a crystal oscillator, one or more latches, or any other digital or analog components for generating appropriate control signals.
In one embodiment, the control logic 726 may apply at least one electrosurgical signal 728 to the electrosurgical instrument 700. The electrosurgical signal 728 may comprise, in various embodiments, a drive signal 716 for the motor control logic 712, an RF signal applied to the first and second electrodes 709a, 709b in respective first and second jaw members 705a, 705b for electrosurgical treatment of the target tissue 707, or an ultrasonic drive signal to impart ultrasonic motion to the blade 724. The control logic 726 may be configured to vary one or more of the at least one electrosurgical signals 708 to maintain a predetermined rate of change of impedance of the target tissue 707.
In one embodiment, the impedance of the target tissue 707 may increase during the tissue treatment process, which may include the operations of sealing and cutting the target tissue 707, either independently or simultaneously, for example. As the blade 724 is translated along the longitudinal axis, the tissue impedance may generally increase in response to coagulation, tissue welding, and/or cutting of the target tissue 707. In some embodiments, tissue impedance may display a sudden impedance increase indicating successful coagulation (sealing). The increase in impedance may be due to physiological changes in the tissue, a positive temperature coefficient (PTC) material reaching a trigger threshold, etc., and may occur at any point during the tissue treatment process. The change in impedance, either gradual or sudden, may be monitored by the control logic 726 which may modulate one or more electrosurgical signals to maintain the rate of change of impedance at a predetermined level or within a predetermined range. The term modulation is intended to cover any suitable form of signal modulation, such as, for example, amplitude modulation, frequency modulation, phase modulation, or any combination thereof without limitation. The amount of energy, the travel time of the blade 724, or the combination of the two that may be required to maintain the predetermined rate of change of impedance may be related to the thermal mass of the target tissue 707. The thermal mass of any given target tissue 707, in turn, may be related to the type and amount of tissue located at the target tissue 707.
The feedback signal 710 may be used to calculate the rate of change of impedance of the target tissue 707 during the treatment process. In one embodiment, the feedback signal 710 may be indicative of one or more characteristics of the electrosurgical end effector 722 or the target tissue 707, such as, for example, the voltage drop across the target tissue 707, the current flow through the target tissue 707, the first and second electrodes 709a, 709b of the respective first and second jaw members 705a, 705b, or any combination thereof. The feedback signal 710 provides a measurement of the one or more characteristics to the control logic 726, which may then calculate the impedance at the site of the target tissue 707. The feedback signal 710 may be compared over one or more clock cycles of the control logic 726 to generate a rate of change of the impedance. The rate of change of the impedance may be monitored by the control logic 726 during treatment of the target tissue 707, and one or more electrosurgical signals 708 may be modulated by the control logic 726 to maintain the rate of change of impedance at a predetermined rate or within a predetermined range. The predetermined rate or predetermined range may be determined based on the treatment being applied to the target tissue 707. For example, a first predetermined rate may be used for coagulation and cutting of a tissue target 707 at the target site, a second predetermined rate may be used for welding and cutting of a tissue target 707 at the target site, and a third predetermined rate may be used for a combination of treatment including both coagulation and welding.
In another embodiment, a second feedback signal 710′ may be provided by the motor control logic 712 to the control logic 726. The motor 714 may be configured to provide a signal indicating load on the motor 714 during movement of the blade 724. If the blade 724 is transecting a tissue target 707, at the target site, which comprises a thicker tissue type, the load on the motor 714 may be greater than the tissue target 707 at the target site which comprises a thinner tissue type. The motor control circuit 712 may monitor the load on the motor 714 and generate the second feedback signal 710′ indicative of the load. The second feedback signal 710′ may be applied to the control logic 726 which may alter one or more electrosurgical signals 708 in response to the second feedback signal 710′ generated by the motor control logic 712.
In one embodiment, the electrosurgical instrument 700 may be configured to control the movement speed of the blade 724 in response to the first and second feedback signals 710, 710′, alone or in combination. For example, the control logic 726 may modulate a drive control signal 716 applied to the motor control logic 712 to adjust the speed of the motor 714. The drive control signal 716 may be modulated in any suitable manner. For example, the voltage and/or current of the drive control signal 716 may be modulated. In various embodiments, modulation may be based on amplitude, frequency, phase, or any combination thereof, based on voltage and current measurements. In various embodiments, the drive control signal 716 may be a pulsed signal. In such embodiments, the control logic 726 may modulate the drive control signal 716 by changing the pulse width, duty cycle, etc., of the drive signal. By modulating the drive control signal 716, the control logic 726 may ensure proper treatment of the target tissue 707 by increasing or decreasing the speed of the blade 724 to allow a longer or shorter application of energy to the target tissue 707.
In one embodiment, the electrosurgical instrument 700 may be configured to control ultrasonic or RF energy delivered to the electrosurgical end effector 722 in response to the first feedback signal 710, the second feedback signal 710′, or a combination thereof. In one embodiment, the ultrasonic or RF energy may be delivered to the electrosurgical end effector 722. In another embodiment, the RF energy may be delivered to the first and second electrodes 709a, 709b located on respective first and second jaw members 705a, 705b. In another embodiment, the blade 724 may be implemented as an ultrasonic blade, in which case ultrasonic energy may be applied to the ultrasonic blade for cutting the target tissue 707. The control logic 726 may be electrically coupled to a generator (not shown) to generate the ultrasonic or RF energy. The control logic 726 may modulate a generator control signal applied to the generator to adjust an output signal of the generator. By adjusting the output signal of the generator, the control logic 726 can increase or decrease the energy delivered to the target tissue 707. As discussed above, as the coagulation, sealing, or welding of the target tissue 707 increases, the impedance of the target tissue 707 also increases. By modulating the energy delivered to the target tissue 707, the control logic 726 may decrease the amount of time required to adequately coagulate, seal, or weld the target tissue and thereby increase the rate of change of tissue impedance.
At time ‘B,’ the blade speed 816 is increased in response to a decrease in the impedance of the target tissue 707 indicated by the change in the tissue impedance feedback signal 810. From time ‘B’ to time ‘C,’ the blade speed 816 is kept at a constant rate by the control logic 726. During the time period from ‘B’ to ‘C,’ the control logic 726 modulates the electrosurgical energy signal 808 in response to the rate of change of the tissue 707 impedance as indicated by the tissue 707 impedance feedback signal 810. As shown in the illustrated embodiment, the electrosurgical energy signal 808 is modulated over the time period from ‘B’ to ‘C’ to increase or decrease the pulse width or pulse time of the applied electrosurgical energy signal 808 to maintain the rate of change of the tissue 707 impedance at a predetermined rate.
In the illustrated embodiment, the blade 724 reaches a distal-most displacement at time ‘C,’ causing an end-of-stroke algorithm to activate and reverse the direction of the blade 724. Accordingly, the blade 724 is returned to a proximal-most, or starting, position within the end effector 722. During the proximal movement of the blade 724, one or more termination pulses, such as, for example, four termination pulses, may be applied to the end effector 722 by the control logic 726. The termination pulses may be a predetermined pulse pattern independent of the tissue 707 impedance feedback signal 810. Although a method for modulating one or more signals 716, 808 in response to a feedback signal 810 has been described with reference to
In one embodiment, the control logic uses the feedback signal to determine 906 a rate of change of the impedance of the treatment site. The control logic may control 908 the one or more electrosurgical signals to maintain the rate of change of the impedance at a predetermined rate or within a predetermined range. In one embodiment, the predetermined range is a rate of change of the impedance that is equal to or greater than a threshold value. The control logic may monitor the feedback signal during the entire treatment period and modify the at least one electrosurgical signal to maintain the predetermined rate of change of impedance during the treatment period.
In one embodiment, the control logic 1006 may comprise one or more embedded applications implemented as firmware, software, hardware, or any combination thereof. The control logic 1006 may comprise various executable modules such as software, programs, data, drivers, application program interfaces (APIs), and so forth. The firmware may be stored in nonvolatile memory (NVM), such as in bit-masked read-only memory (ROM) or flash memory. In various implementations, storing the firmware in ROM may preserve flash memory. The NVM may comprise other types of memory including, for example, programmable ROM (PROM), erasable programmable ROM (EEPROM), or battery backed random-access memory (RAM) such as dynamic RAM (DRAM), Double-Data-Ram (DDRAM), and/or synchronous DRAM (SDRAM).
In one embodiment, the control logic 1006 comprises a hardware component implemented as a processor 1100 for executing program instructions for monitoring various measurable characteristics of the electrosurgical instrument 700 and generating an output signal for delivering a therapeutic RF signal, sub-therapeutic RF signal, or combination RF signal to the first and second electrodes 709a, 709b. It will be appreciated by those skilled in the art that the control logic 1006 may comprise additional or fewer components and only a simplified version of the control logic 1006 are described herein for conciseness and clarity. In various embodiments, as previously discussed, the hardware component may be implemented as a DSP, PLD, ASIC, circuits, and/or registers. In one embodiment, the processor 1100 may be configured to store and execute computer software program instructions to generate the output signals for driving various components of the ultrasonic surgical instrument 700, such as the first and second electrodes 709a, 709b, the motor control logic 712, the motor 714, or the blade 724.
In one embodiment, under control of one or more software program routines, the processor 1100 executes the methods in accordance with the described embodiments to generate a step function formed by a stepwise waveform of input RF signals 1108 comprising any and/or all inputs 1106 current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T). The stepwise waveforms of the input RF signals 1108 may be generated by forming a piecewise linear combination of constant functions over a plurality of time intervals created by stepping the RF generator module drive signals, e.g., output drive current (I), voltage (V), and/or frequency (f). The time intervals or periods (T) may be predetermined (e.g., fixed and/or programmed by the user) or may be variable. Variable time intervals may be defined by setting the RF signal to a first value and maintaining the RF signal at that value until a change is detected in a monitored characteristic. Examples of monitored characteristics may comprise, for example, tissue impedance, tissue heating, tissue transection, tissue coagulation, and the like. The RF signals generated by the control logic 1006 include, without limitation, therapeutic, sub-therapeutic, and combination RF signals.
In one embodiment, the executable modules comprise one or more step function algorithm(s) 1102 stored in memory that when executed causes the processor 1100 to generate a step function formed by a stepwise waveform of RF signals comprising current (I), voltage (V), and/or frequency (f) for various time intervals or periods (T). The stepwise waveforms of the RF signals may be generated by forming a piecewise linear combination of constant functions over two or more time intervals created by stepping the generator's output drive current (I), voltage (V), and/or frequency (f). The RF signals may be generated either for predetermined fixed time intervals or periods (T) of time or variable time intervals or periods of time in accordance with the one or more stepped output algorithm(s) 1102. Under control of the processor 1100, the control logic 1006 steps (e.g., increment or decrement) the current (I), voltage (V), and/or frequency (f) up or down at a particular resolution for a predetermined period (T) or until a predetermined condition is detected, such as a change in a monitored characteristic (e.g., tissue impedance). The steps can change in programmed increments or decrements. If other steps are desired, the control logic 1006 can increase or decrease the step adaptively based on measured system characteristics.
In various embodiments, the output indicator 1112 may provide visual, audible, and/or tactile feedback to the surgeon, based on output RF signals 1110 supplied by the processor 1100, to indicate the status of a surgical procedure, such as, for example, when tissue sealing and cutting is complete based on a measured characteristic of the electrosurgical instrument 700, e.g., tissue impedance or other measurements as subsequently described. By way of example, and not limitation, visual feedback comprises any type of visual indication device including incandescent lamps or light emitting diodes (LEDs), graphical user interface, display, analog indicator, digital indicator, bar graph display, digital alphanumeric display. By way of example, and not limitation, audible feedback comprises any type of buzzer, computer generated tone, computerized speech, voice user interface (VUI) to interact with computers through a voice/speech platform. By way of example, and not limitation, tactile feedback comprises any type of vibratory feedback provided through the robotic controller.
In one embodiment, the processor 1100 may be configured or programmed to generate a digital current signal 1114 and a digital frequency signal 1118. These signals 1114, 1118 are applied to a direct digital synthesizer (DDS) circuit 1120 to adjust the amplitude and the frequency (f) of the current output signal 1116 to the first and second electrode 709a, 709b. The output of the DDS circuit 1120 is applied to an amplifier 1122 whose output is applied to a transformer 1124. The output of the transformer 1124 is the signal 1116 applied to the first and second electrodes 709a, 709b.
In one embodiment, the control logic 1006 comprises one or more measurement modules or components that may be configured to monitor measurable characteristics of the electrosurgical instrument 700. In embodiment illustrated in
The operation of the control logic 1006 may be programmed to provide a variety of output drive signals to measure electrical properties of current, voltage, power, impedance, and frequency associated with the tissue site 707 and the first and second electrodes 709a, 709b in a therapeutic, sub-therapeutic, or combination state, for example, based on the tissue located between the first and second jaw members 705a, 705b. When the tissue site is a thinner tissue type, the output may be stepped in a first sequence, for example. When the tissue site is a thicker tissue type, the output may be stepped in a second sequence which delivers a higher voltage, current, or time interval to the tissue site 707.
It will be appreciated by those skilled in the art that the current step function set points (e.g., I1, I2, I3) and the time intervals or periods (e.g., T1, T2) of duration for each of the step function set points described above are not limited to the values described herein and may be adjusted to any suitable value as may be desired for a given set of surgical procedures. Additional or fewer current set points and periods of duration may be selected as may be desired for a given set of design characteristics or performance constraints. As previously discussed, the periods may be predetermined by programming or may be variable based on measurable system characteristics. The embodiments are not limited in this context.
Having described operational details of various embodiments of the surgical system 700, operations for the above surgical system 700 may be further described in terms of a process for sealing and cutting a blood vessel employing a surgical instrument comprising the control logic 1006 and the tissue impedance measurement capabilities described with reference to
Accordingly, one technique for sealing and cutting a vessel includes clamping the target tissue between the first and second jaw members 705a, 705b. It will be appreciated that first and second jaw members 705a, 705b may comprise one or more styles of jaws for grasping and sealing tissue, such as, for example, paddle jaw members, serrated jaw members and may include one or more pivoting jaw members for applying pressure to the tissue site 707 located between the first and second jaw members 705a, 705b. In one embodiment, the first and second jaw members 705a, 705b may comprise a blunt dissection portion.
In one embodiment, a first RF signal may be applied to the first and second electrodes 709a, 709b to seal the tissue site 707 located between the first and second jaw members 705a, 705b. By way of example, and not limitation, and in accordance with one implementation of the control logic 726, the control logic 1006 is programmed to output a first RF energy signal f1 for a first period T1 of time is applied to cause therapeutic treatment of the tissue site 707. In one embodiment, the first time period T1 may be determined by measuring one or more characteristics of the tissue site 707, such as, for example, the tissue impedance. As discussed above with respect to
In one embodiment, a second RF signal may be applied to the first and second electrodes 709a, 709b. The second RF signal may be a sub-therapeutic RF signal. The second RF signal may be applied to the tissue site 707 for a second period T2. The current and the voltage applied to the tissue site 707 by the second RF signal may be monitored and used to calculate the impedance of the tissue site 707.
In one embodiment, the tissue/vessel sealing and cutting process may be automated by sensing the impedance Z characteristics of the tissue site 707 to detect when the sealing of the tissue/vessel occurs. The impedance Z can be correlated to the sealing of the tissue site 707 and to the transection/sealing of the vessel to provide a trigger for the processor 1100 to provide a drive signal for the motor control logic 712 to cause the blade 724 to transect the tissue. As previously discussed with reference to
In one embodiment, the control logic 1006 may provide a control signal to the motor control logic 712. The control signal may be generated based upon the impedance Z of the tissue 707. For example, in one embodiment, a certain tissue impedance Z may indicate that the tissue has been successfully sealed by the application of therapeutic RF energy to the tissue site 707. The control logic 1006 may send a control signal to the motor control logic 712 indicating that the tissue impedance Z has reached a predetermined level. The motor control logic 712 may then advance the blade 724 to transect the tissue 707 located between the first and second jaw members 705a, 705b.
In one embodiment, the electrosurgical instrument 700 may be operated in accordance with a programmed step function algorithm responsive to the tissue impedance Z. In one embodiment, a frequency step function output may be initiated based on a comparison of the tissue impedance Z and one or more predetermined thresholds that have been correlated with tissue 707 sealing states. When the tissue impedance Z transitions above or below (e.g., crosses) a threshold, the processor 1100 applies a digital frequency signal 1118 to the DDS circuit 1120 to change the frequency of the drive signal 1116 by a predetermined step in accordance with the step function algorithm(s) 1102 responsive to the tissue impedance Z.
With reference now to
Still with reference to
In one embodiment a robotic surgical system is provided. The robotic surgical system comprises a surgical tool comprising an end effector comprising a first jaw member, a second jaw member, the first and second jaw members comprising corresponding first and second electrodes, and a blade, the end effector configured to receive at least one signal; an actuator for reciprocating the blade along a longitudinal axis; and a control circuit for controlling the actuator, wherein the control circuit: provides the at least one signal to the end effector receives a feedback signal indicative of a tissue impedance of tissue in contact with the end effector; determines a rate of change of the tissue impedance based on the feedback signal; controls the at least one signal to maintain a predetermined rate of change of the tissue impedance.
In one embodiment a surgical tool is provided. The surgical tool comprises an end effector comprising a first jaw member, a second jaw member, the first and second jaw members comprising corresponding first and second electrodes, and a blade, the end effector configured to receive at least one signal; an actuator for reciprocating the blade along a longitudinal axis; and a control circuit for controlling the actuator, wherein the control circuit: provides the at least one signal to the end effector; receives a feedback signal indicative of a tissue impedance of tissue in contact with the end effector; determines a rate of change of the tissue impedance based on the feedback signal; controls the at least one signal to maintain a predetermined rate of change of the tissue impedance.
Applicant also owns the following patent applications that are each incorporated by reference in their respective entireties:
U.S. patent application Ser. No. 13/536,271, filed on Jun. 28, 2012 and entitled “Flexible Drive Member,” now U.S. Patent Application Publication No. 2014-0005708 A1;
U.S. patent application Ser. No. 13/536,288, filed on Jun. 28, 2012 and entitled “Multi-Functional Powered Surgical Device with External Dissection Features,” now U.S. Patent Application Publication No. 2014-0005718 A1;
U.S. patent application Ser. No. 13/536,295, filed on Jun. 28, 2012 and entitled “Rotary Actuatable Closure Arrangement for Surgical End Effector,” now U.S. Patent Application Publication No. 2014-0005676 A1;
U.S. patent application Ser. No. 13/536,326, filed on Jun. 28, 2012 and entitled “Surgical End Effectors Having Angled Tissue-Contacting Surfaces,” now U.S. Patent Application Publication No. 2014-0005653 A1;
U.S. patent application Ser. No. 13/536,303, filed on Jun. 28, 2012 and entitled “Interchangeable End Effector Coupling Arrangement,” now U.S. Pat. No. 9,028,494;
U.S. patent application Ser. No. 13/536,393, filed on Jun. 28, 2012 and entitled “Surgical End Effector Jaw and Electrode Configurations,” now U.S. Patent Application Publication No. 2014-0005640 A1;
U.S. patent application Ser. No. 13/536,362, filed on Jun. 28, 2012 and entitled “Multi-Axis Articulating and Rotating Surgical Tools,”; and now U.S. Patent Application Publication No. 2014-0005662 A1; and
U.S. patent application Ser. No. 13/536,417, filed on Jun. 28, 2012 and entitled “Electrode Connections for Rotary Driven Surgical Tools,” now U.S. Patent Application Publication No. 2014-0005680 A1.
It will be appreciated that the terms “proximal” and “distal” are used throughout the specification with reference to a clinician manipulating one end of an instrument used to treat a patient. The term “proximal” refers to the portion of the instrument closest to the clinician and the term “distal” refers to the portion located furthest from the clinician. It will further be appreciated that for conciseness and clarity, spatial terms such as “vertical,” “horizontal,” “up,” or “down” may be used herein with respect to the illustrated embodiments. However, surgical instruments may be used in many orientations and positions, and these terms are not intended to be limiting or absolute.
Various embodiments of surgical instruments and robotic surgical systems are described herein. It will be understood by those skilled in the art that the various embodiments described herein may be used with the described surgical instruments and robotic surgical systems. The descriptions are provided for example only, and those skilled in the art will understand that the disclosed embodiments are not limited to only the devices disclosed herein, but may be used with any compatible surgical instrument or robotic surgical system.
Reference throughout the specification to “various embodiments,” “some embodiments,” “one example embodiment,” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one example embodiment. Thus, appearances of the phrases “in various embodiments,” “in some embodiments,” “in one example embodiment,” or “in an embodiment” in places throughout the specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics illustrated or described in connection with one example embodiment may be combined, in whole or in part, with features, structures, or characteristics of one or more other embodiments without limitation.
While various embodiments herein have been illustrated by description of several embodiments and while the illustrative embodiments have been described in considerable detail, it is not the intention of the applicant to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications may readily appear to those skilled in the art. For example, it is generally accepted that endoscopic procedures are more common than laparoscopic procedures. Accordingly, the present invention has been discussed in terms of endoscopic procedures and apparatus. However, use herein of terms such as “endoscopic”, should not be construed to limit the present invention to an instrument for use only in conjunction with an endoscopic tube (e.g., trocar). On the contrary, it is believed that the present invention may find use in any procedure where access is limited to a small incision, including but not limited to laparoscopic procedures, as well as open procedures.
It is to be understood that at least some of the figures and descriptions herein have been simplified to illustrate elements that are relevant for a clear understanding of the disclosure, while eliminating, for purposes of clarity, other elements. Those of ordinary skill in the art will recognize, however, that these and other elements may be desirable. However, because such elements are well known in the art, and because they do not facilitate a better understanding of the disclosure, a discussion of such elements is not provided herein.
While several embodiments have been described, it should be apparent, however, that various modifications, alterations and adaptations to those embodiments may occur to persons skilled in the art with the attainment of some or all of the advantages of the disclosure. For example, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. This application is therefore intended to cover all such modifications, alterations and adaptations without departing from the scope and spirit of the disclosure as defined by the appended claims.
Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
| Number | Name | Date | Kind |
|---|---|---|---|
| 969528 | Disbrow | Sep 1910 | A |
| 1570025 | Young | Jan 1926 | A |
| 1813902 | Bovie | Jul 1931 | A |
| 2442966 | Wallace | Jun 1948 | A |
| 2704333 | Calosi et al. | Mar 1955 | A |
| 2736960 | Armstrong | Mar 1956 | A |
| 2849788 | Creek | Sep 1958 | A |
| 2874470 | Richards | Feb 1959 | A |
| 2990616 | Balamuth et al. | Jul 1961 | A |
| RE25033 | Balamuth et al. | Aug 1961 | E |
| 3015961 | Roney | Jan 1962 | A |
| 3053124 | Balamuth et al. | Sep 1962 | A |
| 3082805 | Royce | Mar 1963 | A |
| 3432691 | Shoh | Mar 1969 | A |
| 3433226 | Boyd | Mar 1969 | A |
| 3489930 | Shoh | Jan 1970 | A |
| 3513848 | Winston et al. | May 1970 | A |
| 3526219 | Balamuth | Sep 1970 | A |
| 3554198 | Tatoian et al. | Jan 1971 | A |
| 3614484 | Shoh | Oct 1971 | A |
| 3616375 | Inoue | Oct 1971 | A |
| 3629726 | Popescu | Dec 1971 | A |
| 3636943 | Balamuth | Jan 1972 | A |
| 3668486 | Silver | Jun 1972 | A |
| 3702948 | Balamuth | Nov 1972 | A |
| 3776238 | Peyman et al. | Dec 1973 | A |
| 3805787 | Banko | Apr 1974 | A |
| 3809977 | Balamuth et al. | May 1974 | A |
| 3830098 | Antonevich | Aug 1974 | A |
| 3854737 | Gilliam, Sr. | Dec 1974 | A |
| 3862630 | Balamuth | Jan 1975 | A |
| 3875945 | Friedman | Apr 1975 | A |
| 3885438 | Harris, Sr. et al. | May 1975 | A |
| 3900823 | Sokal et al. | Aug 1975 | A |
| 3918442 | Nikolaev et al. | Nov 1975 | A |
| 3924335 | Balamuth et al. | Dec 1975 | A |
| 3946738 | Newton et al. | Mar 1976 | A |
| 3955859 | Stella et al. | May 1976 | A |
| 3956826 | Perdreaux, Jr. | May 1976 | A |
| 4012647 | Balamuth et al. | Mar 1977 | A |
| 4074719 | Semm | Feb 1978 | A |
| 4156187 | Murry et al. | May 1979 | A |
| 4167944 | Banko | Sep 1979 | A |
| 4188927 | Harris | Feb 1980 | A |
| 4200106 | Douvas et al. | Apr 1980 | A |
| 4203444 | Bonnell et al. | May 1980 | A |
| 4300083 | Heiges | Nov 1981 | A |
| 4302728 | Nakamura | Nov 1981 | A |
| 4306570 | Matthews | Dec 1981 | A |
| 4445063 | Smith | Apr 1984 | A |
| 4491132 | Aikins | Jan 1985 | A |
| 4494759 | Kieffer | Jan 1985 | A |
| 4504264 | Kelman | Mar 1985 | A |
| 4512344 | Barber | Apr 1985 | A |
| 4526571 | Wuchinich | Jul 1985 | A |
| 4545374 | Jacobson | Oct 1985 | A |
| 4574615 | Bower et al. | Mar 1986 | A |
| 4617927 | Manes | Oct 1986 | A |
| 4633119 | Thompson | Dec 1986 | A |
| 4634420 | Spinosa et al. | Jan 1987 | A |
| 4640279 | Beard | Feb 1987 | A |
| 4641053 | Takeda | Feb 1987 | A |
| 4646738 | Trott | Mar 1987 | A |
| 4646756 | Watmough et al. | Mar 1987 | A |
| 4649919 | Thimsen et al. | Mar 1987 | A |
| 4662068 | Polonsky | May 1987 | A |
| 4674502 | Imonti | Jun 1987 | A |
| 4708127 | Abdelghani | Nov 1987 | A |
| 4712722 | Hood et al. | Dec 1987 | A |
| 4808154 | Freeman | Feb 1989 | A |
| 4819635 | Shapiro | Apr 1989 | A |
| 4827911 | Broadwin et al. | May 1989 | A |
| 4832683 | Idemoto et al. | May 1989 | A |
| 4836186 | Scholz | Jun 1989 | A |
| 4838853 | Parisi | Jun 1989 | A |
| 4844064 | Thimsen et al. | Jul 1989 | A |
| 4850354 | McGurk-Burleson et al. | Jul 1989 | A |
| 4852578 | Companion et al. | Aug 1989 | A |
| 4865159 | Jamison | Sep 1989 | A |
| 4867157 | McGurk-Burleson et al. | Sep 1989 | A |
| 4878493 | Pasternak et al. | Nov 1989 | A |
| 4881550 | Kothe | Nov 1989 | A |
| 4896009 | Pawlowski | Jan 1990 | A |
| 4903696 | Stasz et al. | Feb 1990 | A |
| 4915643 | Samejima et al. | Apr 1990 | A |
| 4922902 | Wuchinich et al. | May 1990 | A |
| 4965532 | Sakurai | Oct 1990 | A |
| 4979952 | Kubota et al. | Dec 1990 | A |
| 4981756 | Rhandhawa | Jan 1991 | A |
| 5013956 | Kurozumi et al. | May 1991 | A |
| 5015227 | Broadwin et al. | May 1991 | A |
| 5026370 | Lottick | Jun 1991 | A |
| 5026387 | Thomas | Jun 1991 | A |
| 5042707 | Taheri | Aug 1991 | A |
| 5084052 | Jacobs | Jan 1992 | A |
| 5105117 | Yamaguchi | Apr 1992 | A |
| 5109819 | Custer et al. | May 1992 | A |
| 5112300 | Ureche | May 1992 | A |
| 5123903 | Quaid et al. | Jun 1992 | A |
| 5126618 | Takahashi et al. | Jun 1992 | A |
| D327872 | McMills et al. | Jul 1992 | S |
| 5152762 | McElhenney | Oct 1992 | A |
| 5162044 | Gahn et al. | Nov 1992 | A |
| 5163421 | Bernstein et al. | Nov 1992 | A |
| 5163537 | Radev | Nov 1992 | A |
| 5167725 | Clark et al. | Dec 1992 | A |
| 5174276 | Crockard | Dec 1992 | A |
| D332660 | Rawson et al. | Jan 1993 | S |
| 5176677 | Wuchinich | Jan 1993 | A |
| 5176695 | Dulebohn | Jan 1993 | A |
| 5184605 | Grzeszykowski | Feb 1993 | A |
| 5188102 | Idemoto et al. | Feb 1993 | A |
| D334173 | Liu et al. | Mar 1993 | S |
| 5209719 | Baruch et al. | May 1993 | A |
| 5213569 | Davis | May 1993 | A |
| 5214339 | Naito | May 1993 | A |
| 5218529 | Meyer et al. | Jun 1993 | A |
| 5221282 | Wuchinich | Jun 1993 | A |
| 5226909 | Evans et al. | Jul 1993 | A |
| 5226910 | Kajiyama et al. | Jul 1993 | A |
| 5241236 | Sasaki et al. | Aug 1993 | A |
| 5241968 | Slater | Sep 1993 | A |
| 5242460 | Klein et al. | Sep 1993 | A |
| 5254129 | Alexander | Oct 1993 | A |
| 5257988 | L'Esperance, Jr. | Nov 1993 | A |
| 5261922 | Hood | Nov 1993 | A |
| 5263957 | Davison | Nov 1993 | A |
| 5264925 | Shipp et al. | Nov 1993 | A |
| 5275166 | Vaitekunas et al. | Jan 1994 | A |
| 5275609 | Pingleton et al. | Jan 1994 | A |
| 5282800 | Foshee et al. | Feb 1994 | A |
| 5282817 | Hoogeboom et al. | Feb 1994 | A |
| 5285795 | Ryan et al. | Feb 1994 | A |
| 5300068 | Rosar et al. | Apr 1994 | A |
| 5304115 | Pflueger et al. | Apr 1994 | A |
| D347474 | Olson | May 1994 | S |
| 5312023 | Green et al. | May 1994 | A |
| 5312425 | Evans et al. | May 1994 | A |
| 5322055 | Davison et al. | Jun 1994 | A |
| 5324299 | Davison et al. | Jun 1994 | A |
| 5326013 | Green et al. | Jul 1994 | A |
| 5326342 | Pflueger et al. | Jul 1994 | A |
| 5344420 | Hilal et al. | Sep 1994 | A |
| 5345937 | Middleman et al. | Sep 1994 | A |
| 5346502 | Estabrook et al. | Sep 1994 | A |
| 5353474 | Good et al. | Oct 1994 | A |
| 5357164 | Imabayashi et al. | Oct 1994 | A |
| 5357423 | Weaver et al. | Oct 1994 | A |
| 5359994 | Krauter et al. | Nov 1994 | A |
| 5366466 | Christian et al. | Nov 1994 | A |
| 5370645 | Klicek et al. | Dec 1994 | A |
| 5371429 | Manna | Dec 1994 | A |
| 5374813 | Shipp | Dec 1994 | A |
| D354564 | Medema | Jan 1995 | S |
| 5381067 | Greenstein et al. | Jan 1995 | A |
| 5387215 | Fisher | Feb 1995 | A |
| 5389098 | Tsuruta et al. | Feb 1995 | A |
| 5394187 | Shipp | Feb 1995 | A |
| 5396266 | Brimhall | Mar 1995 | A |
| 5403312 | Yates et al. | Apr 1995 | A |
| 5403334 | Evans et al. | Apr 1995 | A |
| 5408268 | Shipp | Apr 1995 | A |
| D358887 | Feinberg | May 1995 | S |
| 5411481 | Allen et al. | May 1995 | A |
| 5419761 | Narayanan et al. | May 1995 | A |
| 5421829 | Olichney et al. | Jun 1995 | A |
| 5423844 | Miller | Jun 1995 | A |
| 5438997 | Sieben et al. | Aug 1995 | A |
| 5445639 | Kuslich et al. | Aug 1995 | A |
| 5449370 | Vaitekunas | Sep 1995 | A |
| 5451220 | Ciervo | Sep 1995 | A |
| 5456684 | Schmidt et al. | Oct 1995 | A |
| 5471988 | Fujio et al. | Dec 1995 | A |
| 5472443 | Cordis et al. | Dec 1995 | A |
| 5478003 | Green et al. | Dec 1995 | A |
| 5483501 | Park et al. | Jan 1996 | A |
| 5486162 | Brumbach | Jan 1996 | A |
| 5490860 | Middle et al. | Feb 1996 | A |
| 5500216 | Julian et al. | Mar 1996 | A |
| 5501654 | Failla et al. | Mar 1996 | A |
| 5505693 | Mackool | Apr 1996 | A |
| 5507738 | Ciervo | Apr 1996 | A |
| 5527331 | Kresch et al. | Jun 1996 | A |
| 5540693 | Fisher | Jul 1996 | A |
| 5558671 | Yates | Sep 1996 | A |
| 5562609 | Brumbach | Oct 1996 | A |
| 5562610 | Brumbach | Oct 1996 | A |
| 5573424 | Poppe | Nov 1996 | A |
| 5577654 | Bishop | Nov 1996 | A |
| 5591187 | Dekel | Jan 1997 | A |
| 5593414 | Shipp et al. | Jan 1997 | A |
| 5601601 | Tal et al. | Feb 1997 | A |
| 5603773 | Campbell | Feb 1997 | A |
| 5607436 | Pratt et al. | Mar 1997 | A |
| 5618304 | Hart et al. | Apr 1997 | A |
| 5618492 | Auten et al. | Apr 1997 | A |
| 5620447 | Smith et al. | Apr 1997 | A |
| 5626595 | Sklar et al. | May 1997 | A |
| 5628760 | Knoepfler | May 1997 | A |
| 5630420 | Vaitekunas | May 1997 | A |
| D381077 | Hunt | Jul 1997 | S |
| 5651780 | Jackson et al. | Jul 1997 | A |
| 5653713 | Michelson | Aug 1997 | A |
| 5669922 | Hood | Sep 1997 | A |
| 5674235 | Parisi | Oct 1997 | A |
| 5678568 | Uchikubo et al. | Oct 1997 | A |
| 5690269 | Bolanos et al. | Nov 1997 | A |
| 5694936 | Fujimoto et al. | Dec 1997 | A |
| 5704534 | Huitema et al. | Jan 1998 | A |
| 5709680 | Yates et al. | Jan 1998 | A |
| 5711472 | Bryan | Jan 1998 | A |
| 5713896 | Nardella | Feb 1998 | A |
| 5717306 | Shipp | Feb 1998 | A |
| 5728130 | Ishikawa et al. | Mar 1998 | A |
| 5730752 | Alden et al. | Mar 1998 | A |
| 5733074 | Stöck et al. | Mar 1998 | A |
| 5741226 | Strukel et al. | Apr 1998 | A |
| 5766164 | Mueller et al. | Jun 1998 | A |
| 5772659 | Becker et al. | Jun 1998 | A |
| 5792135 | Madhani et al. | Aug 1998 | A |
| 5792138 | Shipp | Aug 1998 | A |
| 5792165 | Klieman et al. | Aug 1998 | A |
| 5805140 | Rosenberg et al. | Sep 1998 | A |
| 5808396 | Boukhny | Sep 1998 | A |
| 5810859 | DiMatteo et al. | Sep 1998 | A |
| 5817084 | Jensen | Oct 1998 | A |
| 5817119 | Klieman et al. | Oct 1998 | A |
| 5823197 | Edwards | Oct 1998 | A |
| 5827323 | Klieman et al. | Oct 1998 | A |
| 5828160 | Sugishita | Oct 1998 | A |
| 5833696 | Whitfield et al. | Nov 1998 | A |
| 5836897 | Sakurai et al. | Nov 1998 | A |
| 5836957 | Schulz et al. | Nov 1998 | A |
| 5843109 | Mehta et al. | Dec 1998 | A |
| 5851212 | Zirps et al. | Dec 1998 | A |
| 5858018 | Shipp et al. | Jan 1999 | A |
| 5873873 | Smith et al. | Feb 1999 | A |
| 5873882 | Straub et al. | Feb 1999 | A |
| 5878193 | Wang et al. | Mar 1999 | A |
| 5879364 | Bromfield et al. | Mar 1999 | A |
| 5883615 | Fago et al. | Mar 1999 | A |
| 5893835 | Witt et al. | Apr 1999 | A |
| 5897523 | Wright et al. | Apr 1999 | A |
| 5897569 | Kellogg et al. | Apr 1999 | A |
| 5903607 | Tailliet | May 1999 | A |
| 5904681 | West, Jr. | May 1999 | A |
| 5906627 | Spaulding | May 1999 | A |
| 5906628 | Miyawaki et al. | May 1999 | A |
| 5911699 | Anis et al. | Jun 1999 | A |
| 5916229 | Evans | Jun 1999 | A |
| 5929846 | Rosenberg et al. | Jul 1999 | A |
| 5935143 | Hood | Aug 1999 | A |
| 5935144 | Estabrook | Aug 1999 | A |
| 5938633 | Beaupre | Aug 1999 | A |
| 5944718 | Austin et al. | Aug 1999 | A |
| 5944737 | Tsonton et al. | Aug 1999 | A |
| 5947984 | Whipple | Sep 1999 | A |
| 5954736 | Bishop et al. | Sep 1999 | A |
| 5954746 | Holthaus et al. | Sep 1999 | A |
| 5957882 | Nita et al. | Sep 1999 | A |
| 5957943 | Vaitekunas | Sep 1999 | A |
| 5968007 | Simon et al. | Oct 1999 | A |
| 5968060 | Kellogg | Oct 1999 | A |
| 5974342 | Petrofsky | Oct 1999 | A |
| D416089 | Barton et al. | Nov 1999 | S |
| 5980510 | Tsonton et al. | Nov 1999 | A |
| 5980546 | Hood | Nov 1999 | A |
| 5989274 | Davison et al. | Nov 1999 | A |
| 5989275 | Estabrook et al. | Nov 1999 | A |
| 5993465 | Shipp et al. | Nov 1999 | A |
| 5993972 | Reich et al. | Nov 1999 | A |
| 5994855 | Lundell et al. | Nov 1999 | A |
| 6024741 | Williamson, IV et al. | Feb 2000 | A |
| 6024750 | Mastri et al. | Feb 2000 | A |
| 6027515 | Cimino | Feb 2000 | A |
| 6031526 | Shipp | Feb 2000 | A |
| 6033375 | Brumbach | Mar 2000 | A |
| 6033399 | Gines | Mar 2000 | A |
| 6036667 | Manna et al. | Mar 2000 | A |
| 6036707 | Spaulding | Mar 2000 | A |
| 6048224 | Kay | Apr 2000 | A |
| 6050943 | Slayton et al. | Apr 2000 | A |
| 6051010 | DiMatteo et al. | Apr 2000 | A |
| 6056735 | Okada et al. | May 2000 | A |
| 6063098 | Houser et al. | May 2000 | A |
| 6066132 | Chen et al. | May 2000 | A |
| 6066151 | Miyawaki et al. | May 2000 | A |
| 6068627 | Orszulak et al. | May 2000 | A |
| 6068647 | Witt et al. | May 2000 | A |
| 6077285 | Boukhny | Jun 2000 | A |
| 6083191 | Rose | Jul 2000 | A |
| 6086584 | Miller | Jul 2000 | A |
| 6090120 | Wright et al. | Jul 2000 | A |
| 6096033 | Tu et al. | Aug 2000 | A |
| 6099542 | Cohn et al. | Aug 2000 | A |
| 6109500 | Alli et al. | Aug 2000 | A |
| 6110127 | Suzuki | Aug 2000 | A |
| 6113594 | Savage | Sep 2000 | A |
| 6117152 | Huitema | Sep 2000 | A |
| 6126629 | Perkins | Oct 2000 | A |
| 6129735 | Okada et al. | Oct 2000 | A |
| 6129740 | Michelson | Oct 2000 | A |
| 6132368 | Cooper | Oct 2000 | A |
| 6132448 | Perez et al. | Oct 2000 | A |
| 6139320 | Hahn | Oct 2000 | A |
| 6139561 | Shibata et al. | Oct 2000 | A |
| 6142615 | Qiu et al. | Nov 2000 | A |
| 6142994 | Swanson et al. | Nov 2000 | A |
| 6147560 | Erhage et al. | Nov 2000 | A |
| 6152902 | Christian et al. | Nov 2000 | A |
| 6154198 | Rosenberg | Nov 2000 | A |
| 6159160 | Hsei et al. | Dec 2000 | A |
| 6159175 | Strukel et al. | Dec 2000 | A |
| 6162194 | Shipp | Dec 2000 | A |
| 6165150 | Banko | Dec 2000 | A |
| 6174310 | Kirwan, Jr. | Jan 2001 | B1 |
| 6179853 | Sachse et al. | Jan 2001 | B1 |
| 6183426 | Akisada et al. | Feb 2001 | B1 |
| 6193709 | Miyawaki et al. | Feb 2001 | B1 |
| 6204592 | Hur | Mar 2001 | B1 |
| 6205855 | Pfeiffer | Mar 2001 | B1 |
| 6206844 | Reichel et al. | Mar 2001 | B1 |
| 6210402 | Olsen et al. | Apr 2001 | B1 |
| 6210403 | Klicek | Apr 2001 | B1 |
| 6214023 | Whipple et al. | Apr 2001 | B1 |
| 6228080 | Gines | May 2001 | B1 |
| 6231565 | Tovey et al. | May 2001 | B1 |
| 6233476 | Strommer et al. | May 2001 | B1 |
| 6238366 | Savage et al. | May 2001 | B1 |
| 6245065 | Panescu et al. | Jun 2001 | B1 |
| 6252110 | Uemura et al. | Jun 2001 | B1 |
| D444365 | Bass et al. | Jul 2001 | S |
| D445092 | Lee | Jul 2001 | S |
| D445764 | Lee | Jul 2001 | S |
| 6254623 | Haibel, Jr. et al. | Jul 2001 | B1 |
| 6257241 | Wampler | Jul 2001 | B1 |
| 6258034 | Hanafy | Jul 2001 | B1 |
| 6267761 | Ryan | Jul 2001 | B1 |
| 6270831 | Kumar et al. | Aug 2001 | B2 |
| 6273852 | Lehe et al. | Aug 2001 | B1 |
| 6274963 | Estabrook et al. | Aug 2001 | B1 |
| 6277115 | Saadat | Aug 2001 | B1 |
| 6278218 | Madan et al. | Aug 2001 | B1 |
| 6280407 | Manna et al. | Aug 2001 | B1 |
| 6283981 | Beaupre | Sep 2001 | B1 |
| 6287344 | Wampler et al. | Sep 2001 | B1 |
| 6290575 | Shipp | Sep 2001 | B1 |
| 6306157 | Shchervinsky | Oct 2001 | B1 |
| 6309400 | Beaupre | Oct 2001 | B2 |
| 6319221 | Savage et al. | Nov 2001 | B1 |
| 6325795 | Lindemann et al. | Dec 2001 | B1 |
| 6325799 | Goble | Dec 2001 | B1 |
| 6325811 | Messerly | Dec 2001 | B1 |
| 6328751 | Beaupre | Dec 2001 | B1 |
| 6332891 | Himes | Dec 2001 | B1 |
| 6338657 | Harper et al. | Jan 2002 | B1 |
| 6340352 | Okada et al. | Jan 2002 | B1 |
| 6350269 | Shipp et al. | Feb 2002 | B1 |
| 6352532 | Kramer et al. | Mar 2002 | B1 |
| 6358264 | Banko | Mar 2002 | B2 |
| 6364888 | Niemeyer et al. | Apr 2002 | B1 |
| 6379320 | Lafon et al. | Apr 2002 | B1 |
| D457958 | Dycus et al. | May 2002 | S |
| 6383194 | Pothula | May 2002 | B1 |
| 6384690 | Wilhelmsson et al. | May 2002 | B1 |
| 6387109 | Davison et al. | May 2002 | B1 |
| 6388657 | Natoli | May 2002 | B1 |
| 6391042 | Cimino | May 2002 | B1 |
| 6398779 | Buysse et al. | Jun 2002 | B1 |
| 6402743 | Orszulak et al. | Jun 2002 | B1 |
| 6402748 | Schoenman et al. | Jun 2002 | B1 |
| 6405733 | Fogarty et al. | Jun 2002 | B1 |
| 6416486 | Wampler | Jul 2002 | B1 |
| 6423073 | Bowman | Jul 2002 | B2 |
| 6423082 | Houser et al. | Jul 2002 | B1 |
| 6428539 | Baxter et al. | Aug 2002 | B1 |
| 6432118 | Messerly | Aug 2002 | B1 |
| 6436114 | Novak et al. | Aug 2002 | B1 |
| 6436115 | Beaupre | Aug 2002 | B1 |
| 6440062 | Ouchi | Aug 2002 | B1 |
| 6443968 | Holthaus et al. | Sep 2002 | B1 |
| 6443969 | Novak et al. | Sep 2002 | B1 |
| 6449006 | Shipp | Sep 2002 | B1 |
| 6454781 | Witt et al. | Sep 2002 | B1 |
| 6454782 | Schwemberger | Sep 2002 | B1 |
| 6458142 | Faller et al. | Oct 2002 | B1 |
| 6475215 | Tanrisever | Nov 2002 | B1 |
| 6480796 | Wiener | Nov 2002 | B2 |
| 6485490 | Wampler et al. | Nov 2002 | B2 |
| 6491708 | Madan et al. | Dec 2002 | B2 |
| 6497715 | Satou | Dec 2002 | B2 |
| 6500176 | Truckai et al. | Dec 2002 | B1 |
| 6500188 | Harper et al. | Dec 2002 | B2 |
| 6500312 | Wedekamp | Dec 2002 | B2 |
| 6506208 | Hunt et al. | Jan 2003 | B2 |
| 6511478 | Burnside et al. | Jan 2003 | B1 |
| 6511493 | Moutafis et al. | Jan 2003 | B1 |
| 6514267 | Jewett | Feb 2003 | B2 |
| 6524251 | Rabiner et al. | Feb 2003 | B2 |
| 6524316 | Nicholson et al. | Feb 2003 | B1 |
| 6527736 | Attinger et al. | Mar 2003 | B1 |
| 6533784 | Truckai et al. | Mar 2003 | B2 |
| 6537272 | Christopherson et al. | Mar 2003 | B2 |
| 6537291 | Friedman et al. | Mar 2003 | B2 |
| 6543452 | Lavigne | Apr 2003 | B1 |
| 6543456 | Freeman | Apr 2003 | B1 |
| 6544260 | Markel et al. | Apr 2003 | B1 |
| 6558376 | Bishop | May 2003 | B2 |
| 6561983 | Cronin et al. | May 2003 | B2 |
| 6565558 | Lindenmeier et al. | May 2003 | B1 |
| 6572563 | Ouchi | Jun 2003 | B2 |
| 6572632 | Zisterer et al. | Jun 2003 | B2 |
| 6575969 | Rittman, III et al. | Jun 2003 | B1 |
| 6582427 | Goble et al. | Jun 2003 | B1 |
| 6582451 | Marucci et al. | Jun 2003 | B1 |
| D477408 | Bromley | Jul 2003 | S |
| 6588277 | Giordano et al. | Jul 2003 | B2 |
| 6589200 | Schwemberger et al. | Jul 2003 | B1 |
| 6589239 | Khandkar et al. | Jul 2003 | B2 |
| 6607540 | Shipp | Aug 2003 | B1 |
| 6610059 | West, Jr. | Aug 2003 | B1 |
| 6616450 | Mossle et al. | Sep 2003 | B2 |
| 6619529 | Green et al. | Sep 2003 | B2 |
| 6623500 | Cook et al. | Sep 2003 | B1 |
| 6623501 | Heller et al. | Sep 2003 | B2 |
| 6626848 | Neuenfeldt | Sep 2003 | B2 |
| 6626926 | Friedman et al. | Sep 2003 | B2 |
| 6629974 | Penny et al. | Oct 2003 | B2 |
| 6633234 | Wiener et al. | Oct 2003 | B2 |
| 6644532 | Green et al. | Nov 2003 | B2 |
| 6652513 | Panescu et al. | Nov 2003 | B2 |
| 6652539 | Shipp et al. | Nov 2003 | B2 |
| 6652545 | Shipp et al. | Nov 2003 | B2 |
| 6656132 | Ouchi | Dec 2003 | B1 |
| 6656177 | Truckai et al. | Dec 2003 | B2 |
| 6660017 | Beaupre | Dec 2003 | B2 |
| 6662127 | Wiener et al. | Dec 2003 | B2 |
| 6663941 | Brown et al. | Dec 2003 | B2 |
| 6666860 | Takahashi | Dec 2003 | B1 |
| 6666875 | Sakurai et al. | Dec 2003 | B1 |
| 6669690 | Okada et al. | Dec 2003 | B1 |
| 6669710 | Moutafis et al. | Dec 2003 | B2 |
| 6676660 | Wampler et al. | Jan 2004 | B2 |
| 6678621 | Wiener et al. | Jan 2004 | B2 |
| 6679875 | Honda et al. | Jan 2004 | B2 |
| 6679899 | Wiener et al. | Jan 2004 | B2 |
| 6682544 | Mastri et al. | Jan 2004 | B2 |
| 6685701 | Orszulak et al. | Feb 2004 | B2 |
| 6685703 | Pearson et al. | Feb 2004 | B2 |
| 6689145 | Lee et al. | Feb 2004 | B2 |
| 6689146 | Himes | Feb 2004 | B1 |
| 6716215 | David et al. | Apr 2004 | B1 |
| 6719692 | Kleffner et al. | Apr 2004 | B2 |
| 6719776 | Baxter | Apr 2004 | B2 |
| 6723091 | Goble et al. | Apr 2004 | B2 |
| D490059 | Conway et al. | May 2004 | S |
| 6731047 | Kauf et al. | May 2004 | B2 |
| 6733506 | McDevitt et al. | May 2004 | B1 |
| 6739872 | Turri | May 2004 | B1 |
| 6740079 | Eggers et al. | May 2004 | B1 |
| D491666 | Kimmell et al. | Jun 2004 | S |
| 6743245 | Lobdell | Jun 2004 | B2 |
| 6746284 | Spink, Jr. | Jun 2004 | B1 |
| 6746443 | Morley et al. | Jun 2004 | B1 |
| 6752815 | Beaupre | Jun 2004 | B2 |
| 6755825 | Shoenman et al. | Jun 2004 | B2 |
| 6761698 | Shibata et al. | Jul 2004 | B2 |
| 6762535 | Take et al. | Jul 2004 | B2 |
| 6770072 | Truckai et al. | Aug 2004 | B1 |
| 6773409 | Truckai et al. | Aug 2004 | B2 |
| 6773443 | Truwit et al. | Aug 2004 | B2 |
| 6773444 | Messerly | Aug 2004 | B2 |
| 6778023 | Christensen | Aug 2004 | B2 |
| 6783524 | Anderson et al. | Aug 2004 | B2 |
| 6786382 | Hoffman | Sep 2004 | B1 |
| 6786383 | Stegelmann | Sep 2004 | B2 |
| 6790173 | Saadat et al. | Sep 2004 | B2 |
| 6790216 | Ishikawa | Sep 2004 | B1 |
| 6796981 | Wham et al. | Sep 2004 | B2 |
| D496997 | Dycus et al. | Oct 2004 | S |
| 6802843 | Truckai et al. | Oct 2004 | B2 |
| 6809508 | Donofrio | Oct 2004 | B2 |
| 6810281 | Brock et al. | Oct 2004 | B2 |
| 6827712 | Tovey et al. | Dec 2004 | B2 |
| 6828712 | Battaglin et al. | Dec 2004 | B2 |
| 6835082 | Gonnering | Dec 2004 | B2 |
| 6849073 | Hoey et al. | Feb 2005 | B2 |
| 6860878 | Brock | Mar 2005 | B2 |
| 6863676 | Lee et al. | Mar 2005 | B2 |
| 6869439 | White et al. | Mar 2005 | B2 |
| 6875220 | Du et al. | Apr 2005 | B2 |
| 6877647 | Ratcliff et al. | Apr 2005 | B2 |
| 6882439 | Ishijima | Apr 2005 | B2 |
| 6887209 | Kadziauskas et al. | May 2005 | B2 |
| 6887252 | Okada et al. | May 2005 | B1 |
| 6899685 | Kermode et al. | May 2005 | B2 |
| 6905497 | Truckai et al. | Jun 2005 | B2 |
| 6908472 | Wiener et al. | Jun 2005 | B2 |
| 6913579 | Truckai et al. | Jul 2005 | B2 |
| 6915623 | Dey et al. | Jul 2005 | B2 |
| 6923804 | Eggers et al. | Aug 2005 | B2 |
| 6926712 | Phan | Aug 2005 | B2 |
| 6926716 | Baker et al. | Aug 2005 | B2 |
| 6929602 | Hirakui et al. | Aug 2005 | B2 |
| 6929632 | Nita et al. | Aug 2005 | B2 |
| 6929644 | Truckai et al. | Aug 2005 | B2 |
| 6933656 | Matsushita et al. | Aug 2005 | B2 |
| D509589 | Wells | Sep 2005 | S |
| 6942660 | Pantera et al. | Sep 2005 | B2 |
| 6942677 | Nita et al. | Sep 2005 | B2 |
| 6945981 | Donofrio et al. | Sep 2005 | B2 |
| 6946779 | Birgel | Sep 2005 | B2 |
| 6948503 | Refior et al. | Sep 2005 | B2 |
| D511145 | Donofrio et al. | Nov 2005 | S |
| 6974450 | Weber et al. | Dec 2005 | B2 |
| 6976844 | Hickok et al. | Dec 2005 | B2 |
| 6976969 | Messerly | Dec 2005 | B2 |
| 6977495 | Donofrio | Dec 2005 | B2 |
| 6979332 | Adams | Dec 2005 | B2 |
| 6981628 | Wales | Jan 2006 | B2 |
| 6984220 | Wuchinich | Jan 2006 | B2 |
| 6994708 | Manzo | Feb 2006 | B2 |
| 7001335 | Adachi et al. | Feb 2006 | B2 |
| 7011657 | Truckai et al. | Mar 2006 | B2 |
| 7014638 | Michelson | Mar 2006 | B2 |
| 7033357 | Baxter et al. | Apr 2006 | B2 |
| 7037306 | Podany | May 2006 | B2 |
| 7041083 | Chu et al. | May 2006 | B2 |
| 7041088 | Nawrocki et al. | May 2006 | B2 |
| 7041102 | Truckai et al. | May 2006 | B2 |
| 7044949 | Orszulak et al. | May 2006 | B2 |
| 7066893 | Hibner et al. | Jun 2006 | B2 |
| 7066895 | Podany | Jun 2006 | B2 |
| 7070597 | Truckai et al. | Jul 2006 | B2 |
| 7074218 | Washington et al. | Jul 2006 | B2 |
| 7074219 | Levine et al. | Jul 2006 | B2 |
| 7077039 | Gass et al. | Jul 2006 | B2 |
| 7077845 | Hacker et al. | Jul 2006 | B2 |
| 7077853 | Kramer et al. | Jul 2006 | B2 |
| 7083619 | Truckai et al. | Aug 2006 | B2 |
| 7087054 | Truckai et al. | Aug 2006 | B2 |
| 7090672 | Underwood et al. | Aug 2006 | B2 |
| 7101371 | Dycus et al. | Sep 2006 | B2 |
| 7101378 | Salameh et al. | Sep 2006 | B2 |
| 7104834 | Robinson et al. | Sep 2006 | B2 |
| 7108695 | Witt et al. | Sep 2006 | B2 |
| 7111769 | Wales et al. | Sep 2006 | B2 |
| 7112201 | Truckai et al. | Sep 2006 | B2 |
| D531311 | Guerra et al. | Oct 2006 | S |
| 7117034 | Kronberg | Oct 2006 | B2 |
| 7118564 | Ritchie et al. | Oct 2006 | B2 |
| 7124932 | Isaacson et al. | Oct 2006 | B2 |
| 7125409 | Truckai et al. | Oct 2006 | B2 |
| 7128720 | Podany | Oct 2006 | B2 |
| 7131860 | Sartor et al. | Nov 2006 | B2 |
| 7135018 | Ryan et al. | Nov 2006 | B2 |
| 7135030 | Schwemberger et al. | Nov 2006 | B2 |
| 7137980 | Buysse et al. | Nov 2006 | B2 |
| 7144403 | Booth | Dec 2006 | B2 |
| 7153315 | Miller | Dec 2006 | B2 |
| D536093 | Nakajima et al. | Jan 2007 | S |
| 7156189 | Bar-Cohen et al. | Jan 2007 | B1 |
| 7156853 | Muratsu | Jan 2007 | B2 |
| 7157058 | Marhasin et al. | Jan 2007 | B2 |
| 7159750 | Racenet et al. | Jan 2007 | B2 |
| 7160296 | Pearson et al. | Jan 2007 | B2 |
| 7160299 | Baily | Jan 2007 | B2 |
| 7163548 | Stulen et al. | Jan 2007 | B2 |
| 7169144 | Hoey et al. | Jan 2007 | B2 |
| 7169146 | Truckai et al. | Jan 2007 | B2 |
| 7179254 | Pendekanti et al. | Feb 2007 | B2 |
| 7179271 | Friedman et al. | Feb 2007 | B2 |
| 7186253 | Truckai et al. | Mar 2007 | B2 |
| 7189233 | Truckai et al. | Mar 2007 | B2 |
| D541418 | Schechter et al. | Apr 2007 | S |
| 7204820 | Akahoshi | Apr 2007 | B2 |
| 7207997 | Shipp et al. | Apr 2007 | B2 |
| 7210881 | Greenberg | May 2007 | B2 |
| 7211079 | Treat | May 2007 | B2 |
| 7217128 | Atkin et al. | May 2007 | B2 |
| 7217269 | El-Galley et al. | May 2007 | B2 |
| 7220951 | Truckai et al. | May 2007 | B2 |
| 7223229 | Inman et al. | May 2007 | B2 |
| 7229455 | Sakurai et al. | Jun 2007 | B2 |
| 7235071 | Gonnering | Jun 2007 | B2 |
| 7244262 | Wiener et al. | Jul 2007 | B2 |
| 7258688 | Shah et al. | Aug 2007 | B1 |
| 7269873 | Brewer et al. | Sep 2007 | B2 |
| 7273483 | Wiener et al. | Sep 2007 | B2 |
| D552241 | Bromley et al. | Oct 2007 | S |
| 7282048 | Goble et al. | Oct 2007 | B2 |
| 7285895 | Beaupré | Oct 2007 | B2 |
| 7300431 | Dubrovsky | Nov 2007 | B2 |
| 7300435 | Wham et al. | Nov 2007 | B2 |
| 7300446 | Beaupre | Nov 2007 | B2 |
| 7303531 | Lee et al. | Dec 2007 | B2 |
| 7303557 | Wham et al. | Dec 2007 | B2 |
| 7309849 | Truckai et al. | Dec 2007 | B2 |
| 7311706 | Schoenman et al. | Dec 2007 | B2 |
| 7311709 | Truckai et al. | Dec 2007 | B2 |
| 7317955 | McGreevy | Jan 2008 | B2 |
| 7318831 | Alvarez et al. | Jan 2008 | B2 |
| 7326236 | Andreas et al. | Feb 2008 | B2 |
| 7331410 | Yong et al. | Feb 2008 | B2 |
| 7335165 | Truwit et al. | Feb 2008 | B2 |
| 7335997 | Wiener | Feb 2008 | B2 |
| 7337010 | Howard et al. | Feb 2008 | B2 |
| 7353068 | Tanaka et al. | Apr 2008 | B2 |
| 7354440 | Truckai et al. | Apr 2008 | B2 |
| 7364577 | Wham et al. | Apr 2008 | B2 |
| RE40388 | Gines | Jun 2008 | E |
| 7380695 | Doll et al. | Jun 2008 | B2 |
| 7380696 | Shelton, IV et al. | Jun 2008 | B2 |
| 7381209 | Truckai et al. | Jun 2008 | B2 |
| 7390317 | Taylor et al. | Jun 2008 | B2 |
| 7404508 | Smith et al. | Jul 2008 | B2 |
| 7408288 | Hara | Aug 2008 | B2 |
| 7416101 | Shelton, IV et al. | Aug 2008 | B2 |
| 7416437 | Sartor et al. | Aug 2008 | B2 |
| D576725 | Shumer et al. | Sep 2008 | S |
| 7419490 | Falkenstein et al. | Sep 2008 | B2 |
| 7422139 | Shelton, IV et al. | Sep 2008 | B2 |
| 7422463 | Kuo | Sep 2008 | B2 |
| D578643 | Shumer et al. | Oct 2008 | S |
| D578644 | Shumer et al. | Oct 2008 | S |
| D578645 | Shumer et al. | Oct 2008 | S |
| 7431704 | Babaev | Oct 2008 | B2 |
| 7441684 | Shelton, IV et al. | Oct 2008 | B2 |
| 7455208 | Wales et al. | Nov 2008 | B2 |
| 7462181 | Kraft et al. | Dec 2008 | B2 |
| 7464846 | Shelton, IV et al. | Dec 2008 | B2 |
| 7472815 | Shelton, IV et al. | Jan 2009 | B2 |
| 7473263 | Johnston et al. | Jan 2009 | B2 |
| 7479148 | Beaupre | Jan 2009 | B2 |
| 7479160 | Branch et al. | Jan 2009 | B2 |
| 7481775 | Weikel, Jr. et al. | Jan 2009 | B2 |
| 7488285 | Honda et al. | Feb 2009 | B2 |
| 7494468 | Rabiner et al. | Feb 2009 | B2 |
| 7503893 | Kucklick | Mar 2009 | B2 |
| 7503895 | Rabiner et al. | Mar 2009 | B2 |
| 7506790 | Shelton, IV | Mar 2009 | B2 |
| 7506791 | Omaits et al. | Mar 2009 | B2 |
| 7524320 | Tierney et al. | Apr 2009 | B2 |
| 7530986 | Beaupre et al. | May 2009 | B2 |
| 7534243 | Chin et al. | May 2009 | B1 |
| D594983 | Price et al. | Jun 2009 | S |
| 7540871 | Gonnering | Jun 2009 | B2 |
| 7544200 | Houser | Jun 2009 | B2 |
| 7549564 | Boudreaux | Jun 2009 | B2 |
| 7559450 | Wales et al. | Jul 2009 | B2 |
| 7567012 | Namikawa | Jul 2009 | B2 |
| 7569057 | Liu et al. | Aug 2009 | B2 |
| 7572266 | Young et al. | Aug 2009 | B2 |
| 7578820 | Moore et al. | Aug 2009 | B2 |
| 7582084 | Swanson et al. | Sep 2009 | B2 |
| 7582095 | Shipp et al. | Sep 2009 | B2 |
| 7585181 | Olsen | Sep 2009 | B2 |
| 7588176 | Timm et al. | Sep 2009 | B2 |
| 7601119 | Shahinian | Oct 2009 | B2 |
| 7621930 | Houser | Nov 2009 | B2 |
| 7641653 | Dalla Betta et al. | Jan 2010 | B2 |
| 7654431 | Hueil et al. | Feb 2010 | B2 |
| 7659833 | Warner et al. | Feb 2010 | B2 |
| 7665647 | Shelton, IV et al. | Feb 2010 | B2 |
| 7670334 | Hueil et al. | Mar 2010 | B2 |
| 7670338 | Albrecht et al. | Mar 2010 | B2 |
| 7674263 | Ryan | Mar 2010 | B2 |
| 7678069 | Baker et al. | Mar 2010 | B1 |
| 7678125 | Shipp | Mar 2010 | B2 |
| 7682366 | Sakurai et al. | Mar 2010 | B2 |
| 7686770 | Cohen | Mar 2010 | B2 |
| 7686826 | Lee et al. | Mar 2010 | B2 |
| 7688028 | Phillips et al. | Mar 2010 | B2 |
| 7691098 | Wallace et al. | Apr 2010 | B2 |
| 7699846 | Ryan | Apr 2010 | B2 |
| 7713202 | Boukhny et al. | May 2010 | B2 |
| 7714481 | Sakai | May 2010 | B2 |
| 7717915 | Miyazawa | May 2010 | B2 |
| D618797 | Price et al. | Jun 2010 | S |
| 7726537 | Olson et al. | Jun 2010 | B2 |
| 7738969 | Bleich | Jun 2010 | B2 |
| 7740594 | Hibner | Jun 2010 | B2 |
| 7751115 | Song | Jul 2010 | B2 |
| D621503 | Otten et al. | Aug 2010 | S |
| 7766210 | Shelton, IV et al. | Aug 2010 | B2 |
| 7766693 | Sartor et al. | Aug 2010 | B2 |
| 7770774 | Mastri et al. | Aug 2010 | B2 |
| 7770775 | Shelton, IV et al. | Aug 2010 | B2 |
| 7771425 | Dycus et al. | Aug 2010 | B2 |
| 7771444 | Patel et al. | Aug 2010 | B2 |
| 7775972 | Brock et al. | Aug 2010 | B2 |
| 7778733 | Nowlin et al. | Aug 2010 | B2 |
| 7780054 | Wales | Aug 2010 | B2 |
| 7780593 | Ueno et al. | Aug 2010 | B2 |
| 7780651 | Madhani et al. | Aug 2010 | B2 |
| 7780659 | Okada et al. | Aug 2010 | B2 |
| 7784662 | Wales et al. | Aug 2010 | B2 |
| 7796969 | Kelly et al. | Sep 2010 | B2 |
| 7798386 | Schall et al. | Sep 2010 | B2 |
| 7799020 | Shores et al. | Sep 2010 | B2 |
| 7799045 | Masuda | Sep 2010 | B2 |
| 7803152 | Honda et al. | Sep 2010 | B2 |
| 7806891 | Nowlin et al. | Oct 2010 | B2 |
| 7810693 | Broehl et al. | Oct 2010 | B2 |
| 7819819 | Quick et al. | Oct 2010 | B2 |
| D627066 | Romero | Nov 2010 | S |
| 7824401 | Manzo et al. | Nov 2010 | B2 |
| 7832611 | Boyden et al. | Nov 2010 | B2 |
| 7834484 | Sartor | Nov 2010 | B2 |
| 7837699 | Yamada et al. | Nov 2010 | B2 |
| 7845537 | Shelton, IV et al. | Dec 2010 | B2 |
| 7846155 | Houser et al. | Dec 2010 | B2 |
| 7846161 | Dumbauld et al. | Dec 2010 | B2 |
| 7854735 | Houser et al. | Dec 2010 | B2 |
| D631155 | Peine et al. | Jan 2011 | S |
| 7861906 | Doll et al. | Jan 2011 | B2 |
| 7862560 | Marion | Jan 2011 | B2 |
| 7876030 | Taki et al. | Jan 2011 | B2 |
| D631965 | Price et al. | Feb 2011 | S |
| 7878991 | Babaev | Feb 2011 | B2 |
| 7879033 | Sartor et al. | Feb 2011 | B2 |
| 7892606 | Thies et al. | Feb 2011 | B2 |
| 7901423 | Stulen et al. | Mar 2011 | B2 |
| 7905881 | Masuda et al. | Mar 2011 | B2 |
| 7909824 | Masuda et al. | Mar 2011 | B2 |
| 7922061 | Shelton, IV et al. | Apr 2011 | B2 |
| 7922651 | Yamada et al. | Apr 2011 | B2 |
| D637288 | Houghton | May 2011 | S |
| D638540 | Ijiri et al. | May 2011 | S |
| 7936203 | Zimlich | May 2011 | B2 |
| 7951095 | Makin et al. | May 2011 | B2 |
| 7951165 | Golden et al. | May 2011 | B2 |
| 7959050 | Smith et al. | Jun 2011 | B2 |
| 7959626 | Hong et al. | Jun 2011 | B2 |
| 7972329 | Refior et al. | Jul 2011 | B2 |
| 7976544 | McClurken et al. | Jul 2011 | B2 |
| 7981050 | Ritchart et al. | Jul 2011 | B2 |
| 7998157 | Culp et al. | Aug 2011 | B2 |
| 8038693 | Allen | Oct 2011 | B2 |
| 8057498 | Robertson | Nov 2011 | B2 |
| 8058771 | Giordano et al. | Nov 2011 | B2 |
| 8061014 | Smith et al. | Nov 2011 | B2 |
| 8070711 | Bassinger et al. | Dec 2011 | B2 |
| 8070762 | Escudero et al. | Dec 2011 | B2 |
| 8075558 | Truckai et al. | Dec 2011 | B2 |
| 8089197 | Rinner et al. | Jan 2012 | B2 |
| 8097012 | Kagarise | Jan 2012 | B2 |
| 8105323 | Buysse et al. | Jan 2012 | B2 |
| 8142461 | Houser et al. | Mar 2012 | B2 |
| 8152825 | Madan et al. | Apr 2012 | B2 |
| 8157145 | Shelton, Iv et al. | Apr 2012 | B2 |
| 8161977 | Shelton, IV et al. | Apr 2012 | B2 |
| 8162966 | Connor et al. | Apr 2012 | B2 |
| 8172846 | Brunnett et al. | May 2012 | B2 |
| 8172870 | Shipp | May 2012 | B2 |
| 8177800 | Spitz et al. | May 2012 | B2 |
| 8182502 | Stulen et al. | May 2012 | B2 |
| 8186877 | Klimovitch et al. | May 2012 | B2 |
| D661801 | Price et al. | Jun 2012 | S |
| D661802 | Price et al. | Jun 2012 | S |
| D661803 | Price et al. | Jun 2012 | S |
| D661804 | Price et al. | Jun 2012 | S |
| 8197502 | Smith et al. | Jun 2012 | B2 |
| 8210411 | Yates et al. | Jul 2012 | B2 |
| 8226675 | Houser et al. | Jul 2012 | B2 |
| 8235917 | Joseph et al. | Aug 2012 | B2 |
| 8236019 | Houser | Aug 2012 | B2 |
| 8236020 | Smith et al. | Aug 2012 | B2 |
| 8246575 | Viola | Aug 2012 | B2 |
| 8246615 | Behnke | Aug 2012 | B2 |
| 8252012 | Stulen | Aug 2012 | B2 |
| 8253303 | Giordano et al. | Aug 2012 | B2 |
| 8257377 | Wiener et al. | Sep 2012 | B2 |
| 8257387 | Cunningham | Sep 2012 | B2 |
| 8273087 | Kimura et al. | Sep 2012 | B2 |
| D669992 | Schafer et al. | Oct 2012 | S |
| D669993 | Merchant et al. | Oct 2012 | S |
| 8286846 | Smith et al. | Oct 2012 | B2 |
| 8287485 | Kimura et al. | Oct 2012 | B2 |
| 8287528 | Wham et al. | Oct 2012 | B2 |
| 8287532 | Carroll et al. | Oct 2012 | B2 |
| 8298223 | Wham et al. | Oct 2012 | B2 |
| 8298225 | Gilbert | Oct 2012 | B2 |
| 8303576 | Brock | Nov 2012 | B2 |
| 8303580 | Wham et al. | Nov 2012 | B2 |
| 8319400 | Houser et al. | Nov 2012 | B2 |
| 8323302 | Robertson et al. | Dec 2012 | B2 |
| 8333778 | Smith et al. | Dec 2012 | B2 |
| 8333779 | Smith et al. | Dec 2012 | B2 |
| 8334468 | Palmer et al. | Dec 2012 | B2 |
| 8334635 | Voegele et al. | Dec 2012 | B2 |
| 8337407 | Quistgaard et al. | Dec 2012 | B2 |
| 8338726 | Palmer et al. | Dec 2012 | B2 |
| 8344596 | Nield et al. | Jan 2013 | B2 |
| 8348967 | Stulen | Jan 2013 | B2 |
| 8357103 | Mark et al. | Jan 2013 | B2 |
| 8372099 | Deville et al. | Feb 2013 | B2 |
| 8372101 | Smith et al. | Feb 2013 | B2 |
| 8372102 | Stulen et al. | Feb 2013 | B2 |
| 8374670 | Selkee | Feb 2013 | B2 |
| 8377059 | Deville et al. | Feb 2013 | B2 |
| 8377085 | Smith et al. | Feb 2013 | B2 |
| 8382782 | Robertson et al. | Feb 2013 | B2 |
| 8403948 | Deville et al. | Mar 2013 | B2 |
| 8403949 | Palmer et al. | Mar 2013 | B2 |
| 8403950 | Palmer et al. | Mar 2013 | B2 |
| 8418349 | Smith et al. | Apr 2013 | B2 |
| 8419758 | Smith et al. | Apr 2013 | B2 |
| 8419759 | Dietz | Apr 2013 | B2 |
| 8425545 | Smith et al. | Apr 2013 | B2 |
| 8430898 | Wiener et al. | Apr 2013 | B2 |
| 8435257 | Smith et al. | May 2013 | B2 |
| 8439912 | Cunningham et al. | May 2013 | B2 |
| 8439939 | Deville et al. | May 2013 | B2 |
| 8444637 | Podmore et al. | May 2013 | B2 |
| 8444662 | Palmer et al. | May 2013 | B2 |
| 8444664 | Balanev et al. | May 2013 | B2 |
| 8461744 | Wiener et al. | Jun 2013 | B2 |
| 8469981 | Robertson et al. | Jun 2013 | B2 |
| 8479969 | Shelton, IV | Jul 2013 | B2 |
| 8480703 | Nicholas et al. | Jul 2013 | B2 |
| 8485413 | Scheib et al. | Jul 2013 | B2 |
| 8486057 | Behnke, II | Jul 2013 | B2 |
| 8486096 | Robertson et al. | Jul 2013 | B2 |
| 8491578 | Manwaring et al. | Jul 2013 | B2 |
| D687549 | Johnson et al. | Aug 2013 | S |
| 8509318 | Tailliet | Aug 2013 | B2 |
| 8512359 | Whitman et al. | Aug 2013 | B2 |
| 8512365 | Wiener et al. | Aug 2013 | B2 |
| 8523889 | Stulen et al. | Sep 2013 | B2 |
| 8531064 | Robertson et al. | Sep 2013 | B2 |
| 8535340 | Allen | Sep 2013 | B2 |
| 8535341 | Allen | Sep 2013 | B2 |
| 8546996 | Messerly et al. | Oct 2013 | B2 |
| 8546999 | Houser et al. | Oct 2013 | B2 |
| 8568400 | Gilbert | Oct 2013 | B2 |
| 8573461 | Shelton, IV et al. | Nov 2013 | B2 |
| 8573465 | Shelton, IV | Nov 2013 | B2 |
| 8579928 | Robertson et al. | Nov 2013 | B2 |
| 8591506 | Wham et al. | Nov 2013 | B2 |
| 8591536 | Robertson | Nov 2013 | B2 |
| D695407 | Price et al. | Dec 2013 | S |
| D696631 | Price et al. | Dec 2013 | S |
| 8602031 | Reis et al. | Dec 2013 | B2 |
| 8602288 | Shelton, IV et al. | Dec 2013 | B2 |
| 8608745 | Guzman et al. | Dec 2013 | B2 |
| 8616431 | Timm et al. | Dec 2013 | B2 |
| 8623027 | Price et al. | Jan 2014 | B2 |
| 8650728 | Wan et al. | Feb 2014 | B2 |
| 8652155 | Houser et al. | Feb 2014 | B2 |
| 8659208 | Rose et al. | Feb 2014 | B1 |
| 8690582 | Rohrbach et al. | Apr 2014 | B2 |
| 8696366 | Chen et al. | Apr 2014 | B2 |
| 8704425 | Giordano et al. | Apr 2014 | B2 |
| 8709031 | Stulen | Apr 2014 | B2 |
| 8749116 | Messerly et al. | Jun 2014 | B2 |
| 8754570 | Voegele et al. | Jun 2014 | B2 |
| 8764735 | Coe et al. | Jul 2014 | B2 |
| 8773001 | Wiener et al. | Jul 2014 | B2 |
| 8779648 | Giordano et al. | Jul 2014 | B2 |
| 8808319 | Houser et al. | Aug 2014 | B2 |
| 8827992 | Koss et al. | Sep 2014 | B2 |
| 8845537 | Tanaka et al. | Sep 2014 | B2 |
| 8882791 | Stulen | Nov 2014 | B2 |
| 8888776 | Dietz et al. | Nov 2014 | B2 |
| 8888809 | Davison et al. | Nov 2014 | B2 |
| 8900259 | Houser et al. | Dec 2014 | B2 |
| 8911460 | Neurohr et al. | Dec 2014 | B2 |
| 8951248 | Messerly et al. | Feb 2015 | B2 |
| 8951272 | Robertson et al. | Feb 2015 | B2 |
| 8956349 | Aldridge et al. | Feb 2015 | B2 |
| 8961547 | Dietz et al. | Feb 2015 | B2 |
| 8974477 | Yamada | Mar 2015 | B2 |
| 8979890 | Boudreaux | Mar 2015 | B2 |
| 8986302 | Aldridge et al. | Mar 2015 | B2 |
| 9017326 | DiNardo et al. | Apr 2015 | B2 |
| 20010025173 | Ritchie et al. | Sep 2001 | A1 |
| 20010025183 | Shahidi | Sep 2001 | A1 |
| 20010025184 | Messerly | Sep 2001 | A1 |
| 20010031950 | Ryan | Oct 2001 | A1 |
| 20010039419 | Francischelli et al. | Nov 2001 | A1 |
| 20020002377 | Cimino | Jan 2002 | A1 |
| 20020019649 | Sikora et al. | Feb 2002 | A1 |
| 20020022836 | Goble et al. | Feb 2002 | A1 |
| 20020029055 | Bonutti | Mar 2002 | A1 |
| 20020049551 | Friedman et al. | Apr 2002 | A1 |
| 20020052617 | Anis et al. | May 2002 | A1 |
| 20020077550 | Rabiner et al. | Jun 2002 | A1 |
| 20020156466 | Sakurai et al. | Oct 2002 | A1 |
| 20020156493 | Houser et al. | Oct 2002 | A1 |
| 20030014087 | Fang et al. | Jan 2003 | A1 |
| 20030036705 | Hare et al. | Feb 2003 | A1 |
| 20030050572 | Brautigam et al. | Mar 2003 | A1 |
| 20030055443 | Spotnitz | Mar 2003 | A1 |
| 20030114851 | Truckai et al. | Jun 2003 | A1 |
| 20030144680 | Kellogg et al. | Jul 2003 | A1 |
| 20030199794 | Sakurai et al. | Oct 2003 | A1 |
| 20030204199 | Novak et al. | Oct 2003 | A1 |
| 20030212332 | Fenton et al. | Nov 2003 | A1 |
| 20030212363 | Shipp | Nov 2003 | A1 |
| 20030212392 | Fenton et al. | Nov 2003 | A1 |
| 20030212422 | Fenton et al. | Nov 2003 | A1 |
| 20030229344 | Dycus et al. | Dec 2003 | A1 |
| 20040030254 | Babaev | Feb 2004 | A1 |
| 20040030330 | Brassell et al. | Feb 2004 | A1 |
| 20040047485 | Sherrit et al. | Mar 2004 | A1 |
| 20040054364 | Aranyi et al. | Mar 2004 | A1 |
| 20040064151 | Mollenauer | Apr 2004 | A1 |
| 20040092921 | Kadziauskas et al. | May 2004 | A1 |
| 20040092992 | Adams et al. | May 2004 | A1 |
| 20040097912 | Gonnering | May 2004 | A1 |
| 20040097919 | Wellman et al. | May 2004 | A1 |
| 20040097996 | Rabiner et al. | May 2004 | A1 |
| 20040116952 | Sakurai et al. | Jun 2004 | A1 |
| 20040132383 | Langford et al. | Jul 2004 | A1 |
| 20040147934 | Kiester | Jul 2004 | A1 |
| 20040167508 | Wham et al. | Aug 2004 | A1 |
| 20040176686 | Hare et al. | Sep 2004 | A1 |
| 20040199193 | Hayashi et al. | Oct 2004 | A1 |
| 20040204728 | Haefner | Oct 2004 | A1 |
| 20040243147 | Lipow | Dec 2004 | A1 |
| 20040260300 | Gorensek et al. | Dec 2004 | A1 |
| 20050021018 | Anderson et al. | Jan 2005 | A1 |
| 20050021065 | Yamada et al. | Jan 2005 | A1 |
| 20050033337 | Muir et al. | Feb 2005 | A1 |
| 20050049546 | Messerly et al. | Mar 2005 | A1 |
| 20050070800 | Takahashi | Mar 2005 | A1 |
| 20050096683 | Ellins et al. | May 2005 | A1 |
| 20050099824 | Dowling et al. | May 2005 | A1 |
| 20050103819 | Racenet et al. | May 2005 | A1 |
| 20050143769 | White et al. | Jun 2005 | A1 |
| 20050149108 | Cox | Jul 2005 | A1 |
| 20050165345 | Laufer et al. | Jul 2005 | A1 |
| 20050177184 | Easley | Aug 2005 | A1 |
| 20050182339 | Lee et al. | Aug 2005 | A1 |
| 20050188743 | Land | Sep 2005 | A1 |
| 20050192610 | Houser et al. | Sep 2005 | A1 |
| 20050203504 | Wham et al. | Sep 2005 | A1 |
| 20050209620 | Du et al. | Sep 2005 | A1 |
| 20050222598 | Ho et al. | Oct 2005 | A1 |
| 20050234484 | Houser et al. | Oct 2005 | A1 |
| 20050249667 | Tuszynski et al. | Nov 2005 | A1 |
| 20050256405 | Makin et al. | Nov 2005 | A1 |
| 20050261581 | Hughes et al. | Nov 2005 | A1 |
| 20050261588 | Makin et al. | Nov 2005 | A1 |
| 20050273090 | Nieman et al. | Dec 2005 | A1 |
| 20050288659 | Kimura et al. | Dec 2005 | A1 |
| 20060030797 | Zhou et al. | Feb 2006 | A1 |
| 20060058825 | Ogura et al. | Mar 2006 | A1 |
| 20060063130 | Hayman et al. | Mar 2006 | A1 |
| 20060066181 | Bromfield et al. | Mar 2006 | A1 |
| 20060074442 | Noriega et al. | Apr 2006 | A1 |
| 20060079879 | Faller et al. | Apr 2006 | A1 |
| 20060084963 | Messerly | Apr 2006 | A1 |
| 20060095046 | Trieu et al. | May 2006 | A1 |
| 20060190034 | Nishizawa et al. | Aug 2006 | A1 |
| 20060206100 | Eskridge et al. | Sep 2006 | A1 |
| 20060206115 | Schomer et al. | Sep 2006 | A1 |
| 20060211943 | Beaupre | Sep 2006 | A1 |
| 20060217729 | Eskridge et al. | Sep 2006 | A1 |
| 20060235306 | Cotter et al. | Oct 2006 | A1 |
| 20060247558 | Yamada | Nov 2006 | A1 |
| 20060253050 | Yoshimine et al. | Nov 2006 | A1 |
| 20060264809 | Hansmann et al. | Nov 2006 | A1 |
| 20070016235 | Tanaka et al. | Jan 2007 | A1 |
| 20070016236 | Beaupre | Jan 2007 | A1 |
| 20070055228 | Berg et al. | Mar 2007 | A1 |
| 20070056596 | Fanney et al. | Mar 2007 | A1 |
| 20070060915 | Kucklick | Mar 2007 | A1 |
| 20070060935 | Schwardt et al. | Mar 2007 | A1 |
| 20070063618 | Bromfield | Mar 2007 | A1 |
| 20070074584 | Talarico et al. | Apr 2007 | A1 |
| 20070106317 | Shelton, IV et al. | May 2007 | A1 |
| 20070129716 | Daw et al. | Jun 2007 | A1 |
| 20070130771 | Ehlert et al. | Jun 2007 | A1 |
| 20070131034 | Ehlert et al. | Jun 2007 | A1 |
| 20070149881 | Rabin | Jun 2007 | A1 |
| 20070162050 | Sartor | Jul 2007 | A1 |
| 20070166663 | Telles et al. | Jul 2007 | A1 |
| 20070173803 | Wham et al. | Jul 2007 | A1 |
| 20070173813 | Odom | Jul 2007 | A1 |
| 20070173872 | Neuenfeldt | Jul 2007 | A1 |
| 20070175949 | Shelton, IV et al. | Aug 2007 | A1 |
| 20070185380 | Kucklick | Aug 2007 | A1 |
| 20070191712 | Messerly et al. | Aug 2007 | A1 |
| 20070219481 | Babaev | Sep 2007 | A1 |
| 20070239028 | Houser et al. | Oct 2007 | A1 |
| 20070239101 | Kellogg | Oct 2007 | A1 |
| 20070249941 | Salehi et al. | Oct 2007 | A1 |
| 20070260234 | McCullagh et al. | Nov 2007 | A1 |
| 20070265560 | Soltani et al. | Nov 2007 | A1 |
| 20070275348 | Lemon | Nov 2007 | A1 |
| 20070282335 | Young et al. | Dec 2007 | A1 |
| 20070287933 | Phan et al. | Dec 2007 | A1 |
| 20080009848 | Paraschiv et al. | Jan 2008 | A1 |
| 20080051812 | Schmitz et al. | Feb 2008 | A1 |
| 20080058585 | Novak et al. | Mar 2008 | A1 |
| 20080058775 | Darian et al. | Mar 2008 | A1 |
| 20080058845 | Shimizu et al. | Mar 2008 | A1 |
| 20080082039 | Babaev | Apr 2008 | A1 |
| 20080082098 | Tanaka et al. | Apr 2008 | A1 |
| 20080114364 | Goldin et al. | May 2008 | A1 |
| 20080125768 | Tahara et al. | May 2008 | A1 |
| 20080140158 | Hamel et al. | Jun 2008 | A1 |
| 20080147092 | Rogge et al. | Jun 2008 | A1 |
| 20080171938 | Masuda et al. | Jul 2008 | A1 |
| 20080172051 | Masuda et al. | Jul 2008 | A1 |
| 20080177268 | Daum et al. | Jul 2008 | A1 |
| 20080188878 | Young | Aug 2008 | A1 |
| 20080200940 | Eichmann et al. | Aug 2008 | A1 |
| 20080208108 | Kimura | Aug 2008 | A1 |
| 20080208231 | Ota et al. | Aug 2008 | A1 |
| 20080214967 | Aranyi et al. | Sep 2008 | A1 |
| 20080234709 | Houser | Sep 2008 | A1 |
| 20080243106 | Coe et al. | Oct 2008 | A1 |
| 20080243162 | Shibata et al. | Oct 2008 | A1 |
| 20080245371 | Gruber | Oct 2008 | A1 |
| 20080249553 | Gruber et al. | Oct 2008 | A1 |
| 20080255423 | Kondo et al. | Oct 2008 | A1 |
| 20080262490 | Williams | Oct 2008 | A1 |
| 20080281200 | Voic et al. | Nov 2008 | A1 |
| 20080281315 | Gines | Nov 2008 | A1 |
| 20080281322 | Sherman et al. | Nov 2008 | A1 |
| 20080287948 | Newton et al. | Nov 2008 | A1 |
| 20090023985 | Ewers | Jan 2009 | A1 |
| 20090036914 | Houser | Feb 2009 | A1 |
| 20090048537 | Lydon et al. | Feb 2009 | A1 |
| 20090054886 | Yachi et al. | Feb 2009 | A1 |
| 20090054894 | Yachi | Feb 2009 | A1 |
| 20090076506 | Baker | Mar 2009 | A1 |
| 20090082716 | Akahoshi | Mar 2009 | A1 |
| 20090112229 | Omori et al. | Apr 2009 | A1 |
| 20090118751 | Wiener et al. | May 2009 | A1 |
| 20090118802 | Mioduski et al. | May 2009 | A1 |
| 20090138006 | Bales et al. | May 2009 | A1 |
| 20090143797 | Smith et al. | Jun 2009 | A1 |
| 20090143799 | Smith et al. | Jun 2009 | A1 |
| 20090143800 | Deville et al. | Jun 2009 | A1 |
| 20090143806 | Witt et al. | Jun 2009 | A1 |
| 20090149801 | Crandall et al. | Jun 2009 | A1 |
| 20090207923 | Dress | Aug 2009 | A1 |
| 20090216157 | Yamada | Aug 2009 | A1 |
| 20090223033 | Houser | Sep 2009 | A1 |
| 20090254077 | Craig | Oct 2009 | A1 |
| 20090254080 | Honda | Oct 2009 | A1 |
| 20090270771 | Takahashi | Oct 2009 | A1 |
| 20090270812 | Litscher et al. | Oct 2009 | A1 |
| 20090270853 | Yachi et al. | Oct 2009 | A1 |
| 20090270899 | Carusillo et al. | Oct 2009 | A1 |
| 20090275940 | Malackowski et al. | Nov 2009 | A1 |
| 20090318945 | Yoshimine et al. | Dec 2009 | A1 |
| 20090327715 | Smith et al. | Dec 2009 | A1 |
| 20100004508 | Naito et al. | Jan 2010 | A1 |
| 20100016785 | Takuma | Jan 2010 | A1 |
| 20100016852 | Manzo et al. | Jan 2010 | A1 |
| 20100022825 | Yoshie | Jan 2010 | A1 |
| 20100030233 | Whitman et al. | Feb 2010 | A1 |
| 20100030248 | Palmer et al. | Feb 2010 | A1 |
| 20100036370 | Mirel et al. | Feb 2010 | A1 |
| 20100042077 | Okada | Feb 2010 | A1 |
| 20100049180 | Wells et al. | Feb 2010 | A1 |
| 20100063525 | Beaupre et al. | Mar 2010 | A1 |
| 20100063528 | Beauprë | Mar 2010 | A1 |
| 20100069940 | Miller et al. | Mar 2010 | A1 |
| 20100158307 | Kubota et al. | Jun 2010 | A1 |
| 20100187283 | Crainich et al. | Jul 2010 | A1 |
| 20100222714 | Muir et al. | Sep 2010 | A1 |
| 20100228264 | Robinson et al. | Sep 2010 | A1 |
| 20100234906 | Koh | Sep 2010 | A1 |
| 20100262134 | Jensen et al. | Oct 2010 | A1 |
| 20100274160 | Yachi et al. | Oct 2010 | A1 |
| 20100280407 | Polster | Nov 2010 | A1 |
| 20100292691 | Brogna | Nov 2010 | A1 |
| 20100298743 | Nield et al. | Nov 2010 | A1 |
| 20100298851 | Nield | Nov 2010 | A1 |
| 20100331742 | Masuda | Dec 2010 | A1 |
| 20110004233 | Muir et al. | Jan 2011 | A1 |
| 20110009850 | Main et al. | Jan 2011 | A1 |
| 20110015631 | Wiener et al. | Jan 2011 | A1 |
| 20110077648 | Lee et al. | Mar 2011 | A1 |
| 20110082486 | Messerly et al. | Apr 2011 | A1 |
| 20110087214 | Giordano et al. | Apr 2011 | A1 |
| 20110087215 | Aldridge et al. | Apr 2011 | A1 |
| 20110087217 | Yates et al. | Apr 2011 | A1 |
| 20110087218 | Boudreaux et al. | Apr 2011 | A1 |
| 20110087256 | Wiener et al. | Apr 2011 | A1 |
| 20110112526 | Fritz et al. | May 2011 | A1 |
| 20110125151 | Strauss et al. | May 2011 | A1 |
| 20110125174 | Babaev | May 2011 | A1 |
| 20110144806 | Sandhu et al. | Jun 2011 | A1 |
| 20110196399 | Robertson et al. | Aug 2011 | A1 |
| 20110224689 | Larkin et al. | Sep 2011 | A1 |
| 20110238065 | Hunt et al. | Sep 2011 | A1 |
| 20110257650 | Deville et al. | Oct 2011 | A1 |
| 20110270126 | Gunday et al. | Nov 2011 | A1 |
| 20110290853 | Shelton, IV et al. | Dec 2011 | A1 |
| 20110290855 | Moore et al. | Dec 2011 | A1 |
| 20110290856 | Shelton, IV et al. | Dec 2011 | A1 |
| 20120004655 | Kim et al. | Jan 2012 | A1 |
| 20120022525 | Dietz et al. | Jan 2012 | A1 |
| 20120022530 | Woodruff et al. | Jan 2012 | A1 |
| 20120059289 | Nield et al. | Mar 2012 | A1 |
| 20120065628 | Naito | Mar 2012 | A1 |
| 20120071863 | Lee et al. | Mar 2012 | A1 |
| 20120078139 | Aldridge et al. | Mar 2012 | A1 |
| 20120078243 | Worrell et al. | Mar 2012 | A1 |
| 20120078244 | Worrell et al. | Mar 2012 | A1 |
| 20120078247 | Worrell et al. | Mar 2012 | A1 |
| 20120078278 | Bales, Jr. et al. | Mar 2012 | A1 |
| 20120080332 | Shelton, IV et al. | Apr 2012 | A1 |
| 20120101495 | Young et al. | Apr 2012 | A1 |
| 20120116379 | Yates et al. | May 2012 | A1 |
| 20120116391 | Houser et al. | May 2012 | A1 |
| 20120116394 | Timm et al. | May 2012 | A1 |
| 20120116395 | Madan et al. | May 2012 | A1 |
| 20120130256 | Buysse et al. | May 2012 | A1 |
| 20120130365 | McLawhorn | May 2012 | A1 |
| 20120136354 | Rupp | May 2012 | A1 |
| 20120138660 | Shelton, IV | Jun 2012 | A1 |
| 20120143211 | Kishi | Jun 2012 | A1 |
| 20120150170 | Buysse et al. | Jun 2012 | A1 |
| 20120165816 | Kersten et al. | Jun 2012 | A1 |
| 20120172873 | Artale et al. | Jul 2012 | A1 |
| 20120172904 | Muir et al. | Jul 2012 | A1 |
| 20120177005 | Liang et al. | Jul 2012 | A1 |
| 20120184946 | Price et al. | Jul 2012 | A1 |
| 20120199630 | Shelton, IV | Aug 2012 | A1 |
| 20120199632 | Spivey et al. | Aug 2012 | A1 |
| 20120203143 | Sanai et al. | Aug 2012 | A1 |
| 20120203247 | Shelton, IV et al. | Aug 2012 | A1 |
| 20120209289 | Duque et al. | Aug 2012 | A1 |
| 20120209303 | Frankhouser et al. | Aug 2012 | A1 |
| 20120210223 | Eppolito | Aug 2012 | A1 |
| 20120215220 | Manzo et al. | Aug 2012 | A1 |
| 20120245582 | Kimball et al. | Sep 2012 | A1 |
| 20120253370 | Ross et al. | Oct 2012 | A1 |
| 20120265196 | Turner et al. | Oct 2012 | A1 |
| 20120269676 | Houser et al. | Oct 2012 | A1 |
| 20120310262 | Messerly et al. | Dec 2012 | A1 |
| 20120330307 | Ladtkow et al. | Dec 2012 | A1 |
| 20130012957 | Shelton, IV et al. | Jan 2013 | A1 |
| 20130012970 | Houser | Jan 2013 | A1 |
| 20130030433 | Heard | Jan 2013 | A1 |
| 20130035680 | Ben-Haim et al. | Feb 2013 | A1 |
| 20130053840 | Krapohl et al. | Feb 2013 | A1 |
| 20130072856 | Frankhouser et al. | Mar 2013 | A1 |
| 20130072857 | Frankhouser et al. | Mar 2013 | A1 |
| 20130079762 | Twomey et al. | Mar 2013 | A1 |
| 20130103023 | Monson et al. | Apr 2013 | A1 |
| 20130103024 | Monson et al. | Apr 2013 | A1 |
| 20130110145 | Weitzman | May 2013 | A1 |
| 20130123776 | Monson et al. | May 2013 | A1 |
| 20130123777 | Monson et al. | May 2013 | A1 |
| 20130123782 | Trees et al. | May 2013 | A1 |
| 20130123822 | Wellman et al. | May 2013 | A1 |
| 20130131660 | Monson et al. | May 2013 | A1 |
| 20130165929 | Muir et al. | Jun 2013 | A1 |
| 20130211397 | Parihar et al. | Aug 2013 | A1 |
| 20130217967 | Mohr et al. | Aug 2013 | A1 |
| 20130226207 | Stulen et al. | Aug 2013 | A1 |
| 20130226208 | Wiener et al. | Aug 2013 | A1 |
| 20130245659 | Robertson et al. | Sep 2013 | A1 |
| 20130267975 | Timm et al. | Oct 2013 | A1 |
| 20130274734 | Maass et al. | Oct 2013 | A1 |
| 20130282003 | Messerly et al. | Oct 2013 | A1 |
| 20130282038 | Dannaher et al. | Oct 2013 | A1 |
| 20130282039 | Wiener et al. | Oct 2013 | A1 |
| 20130285758 | Aldridge et al. | Oct 2013 | A1 |
| 20130289591 | Boudreaux et al. | Oct 2013 | A1 |
| 20130296908 | Schulte et al. | Nov 2013 | A1 |
| 20130338661 | Behnke, II | Dec 2013 | A1 |
| 20130345689 | Ruddenklau et al. | Dec 2013 | A1 |
| 20130345733 | Robertson et al. | Dec 2013 | A1 |
| 20140005640 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005653 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005654 | Batross et al. | Jan 2014 | A1 |
| 20140005656 | Mucilli et al. | Jan 2014 | A1 |
| 20140005661 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005662 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005668 | Rhee et al. | Jan 2014 | A1 |
| 20140005676 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005680 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005681 | Gee et al. | Jan 2014 | A1 |
| 20140005682 | Worrell et al. | Jan 2014 | A1 |
| 20140005701 | Olson et al. | Jan 2014 | A1 |
| 20140005702 | Timm et al. | Jan 2014 | A1 |
| 20140005703 | Stulen et al. | Jan 2014 | A1 |
| 20140005704 | Vakharia et al. | Jan 2014 | A1 |
| 20140005705 | Weir et al. | Jan 2014 | A1 |
| 20140005708 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005718 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140012299 | Stoddard et al. | Jan 2014 | A1 |
| 20140058427 | Robertson | Feb 2014 | A1 |
| 20140066962 | Robertson et al. | Mar 2014 | A1 |
| 20140087569 | Lee | Mar 2014 | A1 |
| 20140107538 | Wiener et al. | Apr 2014 | A1 |
| 20140114327 | Boudreaux et al. | Apr 2014 | A1 |
| 20140135804 | Weisenburgh, II et al. | May 2014 | A1 |
| 20140155921 | Price et al. | Jun 2014 | A1 |
| 20140180280 | Sigmon, Jr. | Jun 2014 | A1 |
| 20140243864 | Voegele et al. | Aug 2014 | A1 |
| 20140276738 | Price et al. | Sep 2014 | A1 |
| 20140276970 | Messerly et al. | Sep 2014 | A1 |
| 20140336686 | Houser et al. | Nov 2014 | A1 |
| 20150045819 | Houser et al. | Feb 2015 | A1 |
| 20150066067 | Stulen | Mar 2015 | A1 |
| 20150073460 | Stulen | Mar 2015 | A1 |
| 20150112335 | Boudreaux et al. | Apr 2015 | A1 |
| 20150119914 | Neurohr et al. | Apr 2015 | A1 |
| 20150119915 | Neurohr et al. | Apr 2015 | A1 |
| 20150119916 | Dietz et al. | Apr 2015 | A1 |
| 20150123348 | Robertson et al. | May 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 2003241752 | Sep 2003 | AU |
| 1634601 | Jul 2005 | CN |
| 1640365 | Jul 2005 | CN |
| 1694649 | Nov 2005 | CN |
| 1922563 | Feb 2007 | CN |
| 1951333 | Apr 2007 | CN |
| 101040799 | Sep 2007 | CN |
| 101467917 | Jan 2009 | CN |
| 3904558 | Aug 1990 | DE |
| 19608716 | Apr 1997 | DE |
| 20021619 | Mar 2001 | DE |
| 0136855 | Sep 1984 | EP |
| 0171967 | Feb 1986 | EP |
| 1839599 | Oct 1987 | EP |
| 0336742 | Apr 1989 | EP |
| 0424685 | May 1991 | EP |
| 0443256 | Aug 1991 | EP |
| 0456470 | Nov 1991 | EP |
| 0598976 | Jan 1994 | EP |
| 0677275 | Mar 1995 | EP |
| 0482195 | Jan 1996 | EP |
| 0695535 | Feb 1996 | EP |
| 0741996 | Nov 1996 | EP |
| 0612570 | Jun 1997 | EP |
| 1108394 | Jun 2001 | EP |
| 0908148 | Jan 2002 | EP |
| 1229515 | Aug 2002 | EP |
| 1285634 | Feb 2003 | EP |
| 0908155 | Jun 2003 | EP |
| 0705570 | Apr 2004 | EP |
| 0765637 | Jul 2004 | EP |
| 0870473 | Sep 2005 | EP |
| 0624346 | Nov 2005 | EP |
| 1594209 | Nov 2005 | EP |
| 1199044 | Dec 2005 | EP |
| 1609428 | Dec 2005 | EP |
| 1199043 | Mar 2006 | EP |
| 1433425 | Jun 2006 | EP |
| 1256323 | Sep 2006 | EP |
| 1704824 | Sep 2006 | EP |
| 1749479 | Feb 2007 | EP |
| 1815950 | Aug 2007 | EP |
| 1844720 | Oct 2007 | EP |
| 1862133 | Dec 2007 | EP |
| 1875875 | Jan 2008 | EP |
| 1199045 | Jun 2008 | EP |
| 1964530 | Sep 2008 | EP |
| 1972264 | Sep 2008 | EP |
| 1974771 | Oct 2008 | EP |
| 1435852 | Dec 2008 | EP |
| 1498082 | Dec 2008 | EP |
| 1707131 | Dec 2008 | EP |
| 1997438 | Dec 2008 | EP |
| 1477104 | Jan 2009 | EP |
| 2014218 | Jan 2009 | EP |
| 2042112 | Apr 2009 | EP |
| 1832259 | Jun 2009 | EP |
| 2074959 | Jul 2009 | EP |
| 2106758 | Oct 2009 | EP |
| 2111813 | Oct 2009 | EP |
| 2200145 | Jun 2010 | EP |
| 1214913 | Jul 2010 | EP |
| 2238938 | Oct 2010 | EP |
| 2298154 | Mar 2011 | EP |
| 1510178 | Jun 2011 | EP |
| 2305144 | Jun 2011 | EP |
| 2335630 | Jun 2011 | EP |
| 1502551 | Jul 2011 | EP |
| 2361562 | Aug 2011 | EP |
| 2365608 | Sep 2011 | EP |
| 2422721 | Feb 2012 | EP |
| 1927321 | Apr 2012 | EP |
| 2510891 | Oct 2012 | EP |
| 2316359 | Mar 2013 | EP |
| 1586275 | May 2013 | EP |
| 1616529 | Sep 2013 | EP |
| 2583633 | Oct 2014 | EP |
| 2032221 | Apr 1980 | GB |
| 2379878 | Nov 2004 | GB |
| 2447767 | Aug 2011 | GB |
| 5208761 | Jun 2013 | JO |
| 63-109386 | May 1988 | JP |
| 63-315049 | Dec 1988 | JP |
| H01-151452 | Jun 1989 | JP |
| H01-198540 | Aug 1989 | JP |
| 2-286149 | Nov 1990 | JP |
| H02-292193 | Dec 1990 | JP |
| H04-150847 | May 1992 | JP |
| H04-152942 | May 1992 | JP |
| 05-095955 | Apr 1993 | JP |
| H06-070938 | Mar 1994 | JP |
| 6-104503 | Apr 1994 | JP |
| 6-507081 | Aug 1994 | JP |
| H7-508910 | Oct 1995 | JP |
| 7-308323 | Nov 1995 | JP |
| 8-24266 | Jan 1996 | JP |
| 8-275951 | Oct 1996 | JP |
| H08-299351 | Nov 1996 | JP |
| H08-336545 | Dec 1996 | JP |
| H09-503146 | Mar 1997 | JP |
| H09-135553 | May 1997 | JP |
| H10-005237 | Jan 1998 | JP |
| 10-295700 | Nov 1998 | JP |
| H11-501543 | Feb 1999 | JP |
| H11-128238 | May 1999 | JP |
| H11-192235 | Jul 1999 | JP |
| 11-253451 | Sep 1999 | JP |
| H11-318918 | Nov 1999 | JP |
| 2000-041991 | Feb 2000 | JP |
| 2000-070279 | Mar 2000 | JP |
| 2000-210299 | Aug 2000 | JP |
| 2000-287987 | Oct 2000 | JP |
| 2001-029353 | Feb 2001 | JP |
| 2001-502216 | Feb 2001 | JP |
| 2003612 | Jun 2001 | JP |
| 2001-309925 | Nov 2001 | JP |
| 2002-186901 | Jul 2002 | JP |
| 2002-204808 | Jul 2002 | JP |
| 2002-263579 | Sep 2002 | JP |
| 2002-301086 | Oct 2002 | JP |
| 2002-330977 | Nov 2002 | JP |
| 2002-542690 | Dec 2002 | JP |
| 2003-000612 | Jan 2003 | JP |
| 2003-010201 | Jan 2003 | JP |
| 2003-510158 | Mar 2003 | JP |
| 2003-116870 | Apr 2003 | JP |
| 2003-126110 | May 2003 | JP |
| 2003-310627 | May 2003 | JP |
| 2003-530921 | Oct 2003 | JP |
| 2003-339730 | Dec 2003 | JP |
| 2004-147701 | May 2004 | JP |
| 2005027026 | Jan 2005 | JP |
| 2005-040222 | Feb 2005 | JP |
| 2005-066316 | Mar 2005 | JP |
| 2005-074088 | Mar 2005 | JP |
| 2005-534451 | Nov 2005 | JP |
| 2006-6410 | Jan 2006 | JP |
| 2006-512149 | Apr 2006 | JP |
| 2006-116194 | May 2006 | JP |
| 2006-158525 | Jun 2006 | JP |
| 2006-218296 | Aug 2006 | JP |
| 2006217716 | Aug 2006 | JP |
| 2006-288431 | Oct 2006 | JP |
| 2007-050181 | Mar 2007 | JP |
| 2003-126104 | May 2007 | JP |
| 2007-229454 | Sep 2007 | JP |
| 2007-527747 | Oct 2007 | JP |
| 2008-508065 | Mar 2008 | JP |
| 2008-119250 | May 2008 | JP |
| 2008-521503 | Jun 2008 | JP |
| 2008-212679 | Sep 2008 | JP |
| 2008-284374 | Nov 2008 | JP |
| 2009-511206 | Mar 2009 | JP |
| 2009-517181 | Apr 2009 | JP |
| 4262923 | May 2009 | JP |
| 2009-523567 | Jun 2009 | JP |
| 2009-236177 | Oct 2009 | JP |
| 2010-000336 | Jan 2010 | JP |
| 2010-514923 | May 2010 | JP |
| 2010-540186 | Dec 2010 | JP |
| 2012-235658 | Nov 2012 | JP |
| WO 9222259 | Dec 1992 | WO |
| WO 9308757 | May 1993 | WO |
| WO 9314708 | Aug 1993 | WO |
| WO 9316646 | Sep 1993 | WO |
| WO 9320877 | Oct 1993 | WO |
| WO 9421183 | Sep 1994 | WO |
| WO 9424949 | Nov 1994 | WO |
| WO 9509572 | Apr 1995 | WO |
| WO 9630885 | Oct 1996 | WO |
| WO 9639086 | Dec 1996 | WO |
| WO 9816156 | Apr 1998 | WO |
| WO 9826739 | Jun 1998 | WO |
| WO 9835621 | Aug 1998 | WO |
| WO 9837815 | Sep 1998 | WO |
| WO 9920213 | Apr 1999 | WO |
| WO 9952489 | Oct 1999 | WO |
| WO 0064358 | Nov 2000 | WO |
| WO 0074585 | Dec 2000 | WO |
| WO 0154590 | Aug 2001 | WO |
| WO 0167970 | Sep 2001 | WO |
| WO 0195810 | Dec 2001 | WO |
| WO 0224080 | Mar 2002 | WO |
| WO 0238057 | May 2002 | WO |
| WO 02062241 | Aug 2002 | WO |
| WO 03082133 | Oct 2003 | WO |
| WO 2004012615 | Feb 2004 | WO |
| WO 2004026104 | Apr 2004 | WO |
| WO 2004032754 | Apr 2004 | WO |
| WO 2004032762 | Apr 2004 | WO |
| WO 2004032763 | Apr 2004 | WO |
| WO 2004037095 | May 2004 | WO |
| WO 2004098426 | Nov 2004 | WO |
| WO 2004112618 | Dec 2004 | WO |
| WO 2005122917 | Dec 2005 | WO |
| WO 2006012797 | Feb 2006 | WO |
| WO 2006042210 | Apr 2006 | WO |
| WO 2006058223 | Jun 2006 | WO |
| WO 2006063199 | Jun 2006 | WO |
| WO 2006083988 | Aug 2006 | WO |
| WO 2006119139 | Nov 2006 | WO |
| WO 2006119376 | Nov 2006 | WO |
| WO 2006129465 | Dec 2006 | WO |
| WO 2007008703 | Jan 2007 | WO |
| WO 2007008710 | Jan 2007 | WO |
| WO 2007040818 | Apr 2007 | WO |
| WO 2007047380 | Apr 2007 | WO |
| WO 2007047531 | Apr 2007 | WO |
| WO 2007056590 | May 2007 | WO |
| WO 2007087272 | Aug 2007 | WO |
| WO 2007143665 | Dec 2007 | WO |
| WO 2008016886 | Feb 2008 | WO |
| WO 2008042021 | Apr 2008 | WO |
| WO 2008049084 | Apr 2008 | WO |
| WO 2008051764 | May 2008 | WO |
| WO 2008089174 | Jul 2008 | WO |
| WO 2008118709 | Oct 2008 | WO |
| WO 2008130793 | Oct 2008 | WO |
| WO 2009018406 | Feb 2009 | WO |
| WO 2009027065 | Mar 2009 | WO |
| WO 2009046234 | Apr 2009 | WO |
| WO 2009120992 | Oct 2009 | WO |
| WO 2010068783 | Jun 2010 | WO |
| WO 2011008672 | Jan 2011 | WO |
| WO 2011052939 | May 2011 | WO |
| WO 2011100321 | Aug 2011 | WO |
| WO 2011144911 | Nov 2011 | WO |
| WO 2012061722 | May 2012 | WO |
| WO 2012128362 | Sep 2012 | WO |
| WO 2012135705 | Oct 2012 | WO |
| WO 2012135721 | Oct 2012 | WO |
| WO 2013018934 | Feb 2013 | WO |
| WO 2013062978 | May 2013 | WO |
| Entry |
|---|
| International Search Report for PCT/US2013/045820, dated Oct. 9, 2013 (6 pages). |
| Written Opinion for PCT/US2013/045820, Dec. 31, 2014 (10 pages). |
| Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages). |
| Sherritt et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002. |
| AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006). |
| Lim et al., “A Review of Mechanism Used in Laparoscopic Sugical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003). |
| Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages). |
| Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973). |
| Incropera et al., “Fundamentals of Heat and Mass Transder”, Wiley, New York (1990). (Book—not attached). |
| F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990). |
| Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995). |
| Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging , N.A. Diakides and J. D. Bronzino, Eds. (2008). |
| Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288. |
| Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291. |
| Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970). |
| Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997). |
| Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961). |
| Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000). |
| Covidien 501(k) Summary Sonicision, dated Feb. 24, 2011 (7 pages). |
| Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” Biomedical Engineering, IEEE Transactions on , vol. BME-31, No. 12, pp. 787, 792, Dec. 1984. |
| Fowler, K.R., “A programmable, arbitrary waveform electrosurgical device,” Engineering in Medicine and Biology Society, 1988. Proceedings of the Annual International Conference of the IEEE, vol., No., pp. 1324, 1325 vol. 3, Nov. 4-7, 1988. |
| LaCourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral analysis interpretation of electro-surgical generator nerve and muscle stimulation,” Biomedical Engineering, IEEE Transactions on , vol. 35, No. 7, pp. 505, 509, Jul. 1988. |
| U.S. Appl. No. 13/751,680, filed Jan. 28, 2013. |
| Number | Date | Country | |
|---|---|---|---|
| 20140005667 A1 | Jan 2014 | US |
